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 Thesis Aims 
This thesis brings together a series of experiments to examine the aetiology of acid-
induced distal oesophageal squamous mucosal damage in humans. Firstly, a review 
of the literature on gastro-oesophageal reflux disease, nitrite chemistry, the histology 
of the gastro-oesophageal junction and the role of obesity in reflux disease is 
undertaken. Subsequent chapters report studies of healthy adult volunteers 
investigating the effect salivary nitrite has on gastro-oesophageal reflux and gastric 
emptying. Following this, the effect of salivary nitrite on the post-prandial gastro-
oesophageal morphology is described. Finally, studies examining the relationship 
between age and both the position and parietal cell density of the squamo-columnar 
junction are described.  
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Summary 
 Gastro-oesophageal reflux disease (GORD) is the commonest chronic 
disease in Western countries. Symptomatic GORD is the strongest risk factor 
for the development of oesophageal adenocarcinoma with obesity and male 
sex also linked to the development of neoplasia at this site. Recent decades 
have seen a significant increase in the incidence of this highly lethal cancer 
among Western populations with Scotland having the highest recorded 
incidence worldwide. 
 Human saliva has a high nitrite content derived from the entero-salivary 
recirculation of nitrate in our diet which has resulted from the increased use of 
nitrogenous fertilisers over the past 50-60 years. 
 The luminal chemistry produced at the gastro-oesophageal junction (GOJ) 
when swallowed salivary nitrite reacts with gastric acid, and most notably the 
production of nitric oxide (NO), may explain most of the physiological 
abnormalities that contribute to the pathogenesis of GORD. NO has been 
shown to reduce lower oesophageal sphincter (LOS) pressure, impair 
oesophageal clearance, delay gastric emptying and may be the final mediator 
of transient lower oesophageal sphincter relaxations (TLOSRs). Previous 
studies to investigate the role of this luminal chemistry in the pathogenesis of 
GORD show conflicting results. 
 In addition to the distal oesophageal acidification produced by traditional 
trans-sphincteric reflux, previous studies suggest ‘splaying open’ of the distal 
lower oesophageal sphincter following a meal may expose the gastric cardia 
20 
 
and the most distal oesophageal squamous mucosa to the noxious effects of 
gastric acid. 
 Although the gastric cardia is an important site of pathology in the upper 
gastrointestinal tract, it is a complex and poorly understood area. It has been 
proposed, from autopsy studies, that cardia mucosa itself may be pathological 
and in fact an ‘acquired cardia’ due to metaplasia of the most distal 
oesophageal squamous mucosa. 
 A series of studies were designed to examine the effect of salivary nitrite on 
post-prandial GORD, gastro-oesophageal function and GOJ morphology in 20 
healthy, asymptomatic adult volunteers using high-resolution pH manometry, 
an isotope gastric emptying breath testing and X-ray localisation of the 
squamo-columnar junction (SCJ). 
 Despite an excellent range of salivary nitrite concentrations extending over 
and above the normal physiological range no effect of salivary nitrite on 
gastro-oesophageal reflux, function or morphology was demonstrated. 
However, the studies did confirm, for the first time using high-resolution 
manometry, that distal opening of the LOS occurs after a meal. 
 The relationship of age and obesity to the SCJ position relative to the proximal 
border of the gastro-oesophageal high pressure zone (HPZ) was examined in 
15 Helicobacter Pylori negative healthy volunteers. Strong negative 
correlations were seen between SCJ position relative to the proximal HPZ and 
increasing age, body mass index (BMI) and waist circumference (WC) 
respectively.  These correlations were stronger in the male sub-group. 
21 
 
 In 25 healthy volunteers, parietal cell density was measured from endoscopic 
biopsies taken from  the macroscopic SCJ, 1cm distal to the SCJ, the gastric 
body and the gastric antrum. Again, a strong negative correlation was seen 
between increasing age and parietal cell density at the SCJ. This effect was 
localised to the SCJ and not seen at the other biopsy sites. 
 Our findings suggest that salivary nitrite does not alter gastro-oesophageal 
function, the integrity of the gastro-oesophageal barrier or gastro-oesophageal 
reflux in healthy volunteers. They confirm distal opening of the LOS after 
meals. The strong negative correlations between age and both SCJ position 
relative to the proximal HPZ and parietal cell density support the hypothesis of 
an ‘acquired’ cardia. The development of cardia mucosa may also be linked to 
obesity, visceral obesity and male sex. 
 Future work could examine the carcinogenic effect of salivary nitrite and its 
luminal chemistry but this would require large scale epidemiological research. 
Further, larger clinical studies are needed to investigate the role of distal 
opening of the LOS after meals and to improve our understanding of the 
gastric cardia. Such studies should focus on the role of obesity and posture. 
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Chapter 1 
An Introduction to Gastro-oesophageal 
Reflux Disease (GORD) 
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Chapter 1 
An Introduction to Gastro-oesophageal Reflux Disease (GORD) 
 
1.1. Introduction 
Gastro-oesophageal reflux disease (GORD) is the commonest chronic 
disease affecting Western populations. Heartburn and regurgitation are the cardinal 
symptoms of the disease (1) and pooled data from  studies suggest approximately 
25% have symptoms at least monthly, 12% have at least weekly symptoms and 5% 
suffer heartburn on a daily basis (2). 
GORD is generally defined as the reflux of gastric contents into the 
oesophagus leading to  oesophageal inflammation (oesophagitis), reflux symptoms 
sufficient to impair quality of life, or long-term complications (3). While most people 
experience some physiological gastro-oesophageal reflux after meals, such 
episodes are not usually associated with pathological signs or symptoms (4). GORD 
occurs due to an imbalance between the protective mechanisms in the distal 
oesophagus and the harmful effects of refluxed gastric acid, pepsin and bile on 
oesophageal mucosa. 
 
1.2. The normal oesophagus and anti-reflux mechanisms 
The oesophagus is a muscular tube approximately 25cm long, composed of 
inner circular and outer longitudinal muscle layers. It is lined with stratified squamous 
epithelium. The tight intercellular junctions of these squamous cells and the 
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production of a protective barrier of mucous and bicarbonate is designed to protect 
the epithelium from penetration by luminal molecules. However, unlike the columnar 
gastric mucosa, the squamous mucosa of the oesophagus is sensitive to damage 
from the highly acidic gastric juice (pH 2-3) contained in the stomach. Digestive 
enzymes, such as pepsin, and duodenal juices, including bile, which are contained in 
the gastric juice may also damage squamous oesophageal mucosa. 
 A pressure gradient exists between the abdomen and thorax, exacerbated by 
the negative intra-thoracic pressure and increased intra-gastric pressure during 
inspiration and straining. To prevent reflux into the oesophagus of these potentially 
damaging acidic gastric juices, an area of increased pressure must exist at the 
gastro-oesophageal junction. This ‘high pressure zone’ is the primary mechanism of 
defence the human body has against gastro-oesophageal reflux. It consists of the 
lower oesophageal sphincter (LOS) and the crural diaphragm and crucially, not only 
does it provide an area of increased resting pressure, but it is able to compensate for 
the elevations in intragastric pressure produced during inspiration and straining. 
The LOS, or intrinsic sphincter, is a section of specialized smooth muscle in 
the distal oesophagus of approximately 4cm in length. LOS tone is thought to be 
maintained by excitatory neurones with cholinergic innervations which are under the 
control of the vagus nerve (5;6). In healthy individuals, the LOS tonically contracts, 
closing the distal oesophageal lumen and maintaining a pressure of at least 
15mmHg above intra-gastric pressure (7). The sphincter is able to relax in response 
to oesophageal peristalsis to allow the passage of food, liquid or saliva into the 
stomach. This LOS relaxation is mediated by nitric oxide (NO) (8). 
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The human diaphragm is composed of two parts with separate embryological 
origins. The costal diaphragm originates from the ribs, while the crural diaphragm is 
attached to the vertebral column. The crural diaphragm encircles the proximal 2cm of 
the LOS. By contracting on inspiration and during straining, it augments LOS 
pressure and helps prevent reflux. However, studies also demonstrate that it 
prevents reflux during periods of absent LOS pressure, underlining its importance as 
an anti-reflux barrier (9;10). As a result, it is often referred to as the ’extrinsic 
sphincter’. In common with the rest of the diaphragm, the crura are innervated by the 
phrenic nerve. However, the crura contract a fraction of a second earlier than the 
costal diaphragm (11). This may be physiologically important to its role as an anti-
reflux barrier, ensuring that pressure at the gastro-oesophageal junction increases 
before alterations in the gastro-oesophageal pressure gradient incurred by 
inspiration or straining. 
The gastric sling fibres (oblique fibres) are located below the LOS and are 
also thought to contribute to the anti-reflux barrier.  Muscle fibres are arranged on 
the greater curvature of the stomach with a gap in the fibres across the lesser curve. 
Due to this arrangement, pressure in the gastric fundus creates a flap that presses 
against the lower end of the oesophagus, again augmenting LOS pressure during 
periods of increased intra-gastric pressure. As a result, this area has been described 
as the gastro-oesophageal ‘flap valve’ (12). 
Once gastric contents reflux into the oesophagus, rapid clearance of the 
refluxate must occur to prevent damage to the squamous oesophageal mucosa 
which is vulnerable to its noxious mixture of gastric acid, pepsin and bile. The normal 
mechanism of clearance is a two-stage process. Firstly, there is clearance of 
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refluxate volume by peristalsis. Peristalsis is a wave of oesophageal circular muscle 
contraction that propagates down the oesophagus to the level of the LOS and may 
be primary or secondary. Primary peristalsis is voluntary and occurs approximately 
60 times per hour. During primary peristalsis, circular muscle contraction is 
accompanied by longitudinal muscle contraction which shortens the oesophagus by 
2-2.5cm (13;14). Secondary peristalsis occurs without a pharyngeal swallow and 
may be provoked by distal oesophageal distension or acidification, both of which can 
occur during episodes of gastro-oesophageal reflux (15). During a reflux episode, 
one or two peristaltic waves will empty the distal oesophagus and only a fraction of 
the refluxate will persist. Residual acid can then be neutralized by swallowed saliva 
(16). The normal gastro-oesophageal anatomy and relevant anti-reflux structures are 
shown in Figure 1.1 
 
1.3. The pathophysiology of GORD 
A minority of GORD patients (20%) will have, as their primary disorder, LOS 
incompetence. This is either due to reduced resting LOS pressure, increased intra-
abdominal pressure (e.g. secondary to obesity or pregnancy) or shortening of the 
LOS (15). Acid exposure in such patients is prolonged, especially when supine, and 
severe GORD with complications is often found (17). 
However, many patients with GORD have a normal resting LOS pressure. 
This apparent contradiction was explained by Dodds et al who discovered that the 
majority of reflux events in both healthy volunteers (18) and reflux patients (19) occur 
during transient lower oesophageal sphincter relaxations (TLOSRs). TLOSRs are 
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defined manometrically as sudden, prolonged relaxations of the LOS not associated 
with swallowing (20). Gastric distension is a potent stimulus for the production of 
TLOSRs and studies have shown that distension with free air (21), a balloon (22) 
and, more importantly, a meal (23) all result in an immediate increase in TLOSRs. 
This helps to explain the increase in reflux events which occurs post-prandially. 
Significantly, during TLOSRs, the activity of the crural diaphragm is also inhibited (9), 
facilitating free reflux of gastric contents into the distal oesophagus. 
The neural pathways underlying TLOSRs are now partly understood. By 
dividing the stomach into separate compartments, Franzi et al (24) were able to 
demonstrate that the cardia region has the lowest threshold for triggering TLOSRs. 
Furthermore, inhibition of the vagal nerve by cooling abolishes TLOSR production, 
suggesting a vago-vagal reflex (25).  The afferent pathway in this reflex arc is 
therefore thought to consist of vagal afferents within the muscle layers of the 
proximal stomach, sensitive to stretching during gastric distension (26). These 
afferent fibres terminate in the nucleus tractus solitarius and the dorsal motor 
nucleus of the vagal nerve in the brainstem (27-29). From here, motor neurones 
project to the enteric nervous system of the LOS (30). 
It would be assumed that GORD patients would have higher rates of TLOSRs 
but TLOSRs are not more frequent in GORD patients, simply a higher proportion are 
accompanied by reflux (31). However, the mechanisms behind this are poorly 
understood. 
As previously described, the gastro-oesophageal ‘high pressure zone’, the 
primary anti-reflux barrier, consists of both the LOS and the crural diaphragm. A 
hiatus hernia occurs from spatial separation of these normally overlapping and 
28 
 
complimentary structures with the proximal stomach migrating above the level of the 
diaphragm in the thorax. This is a common endoscopic and radiological finding in 
patients with GORD. A large hiatus hernia certainly predisposes to GORD (32) and 
is associated with an increased risk of oesophagitis (33). Not only does it result in a 
reduction in peak LOS pressure (34) but the presence of a hiatus hernia predisposes 
to increased rates of TLOSRs (35), interferes with primary peristalsis leading to 
inadequate clearance of refluxate (36) and provides an opportunity for accumulation 
of gastric contents in the hiatal sac, facilitating reflux during swallow-induced LOS 
relaxations (37). Finally, in patients with a hiatus hernia, the absence of the gastro-
oesophageal flap valve and loss of an intra-abdominal portion of the oesophagus 
may also contribute to reflux (38). 
An unbuffered ‘pocket’ of acid in the proximal stomach and cardia region has 
also been described after a meal (39). Studies have shown it to be enlarged in reflux 
patients compared with health volunteers (40) and it may contribute to distal 
oesophageal exposure post-prandially (41). 
Several studies have examined the influence of solid and liquid gastric 
emptying on GORD with conflicting results. Some studies show high rates of delayed 
gastric emptying in GORD patients compared to healthy controls (42;43) while in 
others (44-46) rates are equivalent. However, it is likely that in a small number of 
GORD patients delayed gastric emptying contributes both by increasing the amount 
of fluid available for reflux post-prandially and by increasing the rate of TLOSRs due 
to an associated increase in gastric distension. 
Lifestyle factors and drugs may contribute towards the pathogenesis of GORD 
by causing reduced LOS pressures or inappropriate relaxation of the LOS. Obesity 
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leads to increased intra-abdominal pressure increasing the gradient across the 
gastro-oesophageal ‘high pressure zone’. As a result it may disrupt the LOS (47), it 
may also lead to the development of a hiatus hernia due to mechanical pressures on 
the diaphragm  and may increase the number of TLORSs (48). Systematic reviews 
(49) suggest an association between increased body mass index (BMI >25kg/m2) 
and reflux symptoms (OR 1.43) while a similar association is seen with the risk of 
oesophagitis (OR 1.76).  Many drugs (e.g. anticholinergics) reduce LOS pressure 
and similar effects are produced by smoking (50), alcohol (51), coffee (52) and 
chocolate (53). Fatty meals reduce LOS pressure as a result of increased CCK 
release in response to duodenal fat, can cause delayed gastric emptying and are 
also associated with increased rates of TLOSRs (22;54;55). 
 
1.4 Complications of GORD 
In addition to the typical symptoms of heartburn and regurgitation, GORD may 
be associated with more serious complications. Inflammation of the oesophagus 
(oesophagitis) can occur and ranges from mild erythema to the development of 
erosions and ulceration. More severe ulceration can progress to the formation of a 
peptic stricture and obstruction of the oesophagus. Barrett’s oesophagus is defined 
as a metaplastic change in the oesophageal squamous mucosa to a specialized 
intestinal epithelium and occurs as a consequence of longstanding GORD (56). It is 
recognized as a premalignant condition and studies estimate the excess risk of 
oesophageal adenocarcinoma to be increased 30 to 60 fold relative to the general 
population risk (57-60). However, the actual risk of oesophageal adenocarcinoma 
may be as low as 0.4% per year (61). 
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Symptomatic gastro-oesophageal reflux is recognized as the strongest risk 
factor for the development of oesophageal adenocarcinoma. A large case-control 
study by Lagergren et al (62) found that the risk of oesophageal adenocarcinoma 
was nearly eight times higher in those experiencing symptoms of heartburn or 
regurgitation at least weekly than in asymptomatic individuals. Symptoms of reflux at 
night were associated with an almost 11-fold increased risk. Oesophageal 
adenocarcinoma continues to be a highly lethal cancer with 5-year survival rates of 
only approximately 10% across Europe (63).  
 
1.5 Recent changes in upper gastrointestinal cancer epidemiology 
The past four decades have seen a significant increase in the incidence of 
oesophageal adenocarcinoma among Western populations (64) with Scotland 
having the highest recorded incidence worldwide (65). In contrast, the incidence of 
carcinoma of the mid and distal stomach has progressively fallen (66).  
Recent data from the Scottish Cancer Registry (2011) show that the incidence 
of oesophageal adenocarcinoma has increased by approximately 250% over the 
past 25 years, from a total of 179 cases in 1985 to 449 cases in 2009 – annual 
incidence rates of oesophageal adenocarcinoma are shown in Figure 1.2. At the 
same time there has been a 43.5% reduction in the number of cases of gastric 
cancer diagnosed, from 1328 in 1985 to 750 in 2008 – annual incidence rates of 
gastric cancer are shown in Figure 1.3. The 5-year survival rate in Scotland is only 
10.8%. 
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The falling incidence of non-cardia gastric cancer may be explained by the 
falling incidence of Helicobacter pylori infection since Helicobacter pylori associated 
atrophic gastritis is a major risk factor for cancer at these site. Debate exists as to 
the aetiology of the increasing incidence of oesophageal adenocarcinoma but the 
reduction in Helicobacter pylori infection has also been proposed as an explanation 
for the increasing incidence of adenocarcinoma of the distal oesophagus. In earlier 
generations, acid secretion would diminish with increasing age due to Helicobacter 
pylori-induced gastric atrophy. However, Helicobacter pylori negative individuals 
maintain their ability to secrete gastric acid throughout their life with the potential for 
greater oesophageal acid exposure as a result. An additional explanation for the 
increase in distal oesophageal adenocarcinomas is the potential carcinogenic and 
refluxogenic effect of reactive nitrogen species generated at this anatomical site. 
 
1.6 Summary 
In summary, GORD is a common chronic condition. Its aetiology is multi-
factorial and not fully understood. It is not only a significant burden on healthcare 
systems in terms of cost but causes significant morbidity and can be associated with 
more serious complications including oesophagitis, peptic strictures, Barrett’s 
oesophagus and, ultimately, oesophageal adenocarcinoma. The incidence of 
oesophageal adenocarcinoma continues to rise, especially in our own country, 
where rates are the highest recorded globally. The cause for this increase in 
incidence remains to be confirmed. 
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Figure 1.1 The normal oesophagus and gastro-oesophageal junction 
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Figure 1.2. Incidence of oesophageal adenocarcinoma in Scotland (1985 -2009) 
 
20
09
20
08
20
07
20
06
20
05
20
04
20
03
20
02
20
01
20
00
19
99
19
98
19
97
19
96
19
95
19
94
19
93
19
92
19
91
19
90
19
89
19
88
19
87
19
86
19
85
1400
1200
1000
800
600
400
200
0
Year
N
u
m
b
e
r 
o
f 
c
a
s
e
s
Incidence of gastric cancer in Scotland (1985-2009)
 
Figure 1.3. Incidence of gastric cancer in Scotland (1985 -2009) 
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Chapter 2 
The Salivary Nitrite Hypothesis 
 
2.1 Salivary nitrite production from dietary nitrate 
Human saliva has a high nitrite concentration, derived from the entero-salivary 
recirculation of nitrate. Once it is ingested, nitrate is absorbed into the bloodstream 
from the small intestine and supplemented by a small amount of endogenous nitrate. 
Entero-salivary recirculation results in 25% of this nitrate being actively secreted by 
the salivary glands (67). Bacteria in the mouth then enzymatically convert between 
10 and 90% of this nitrate in saliva to nitrite (68). The production of nitrite from the 
entero-salivary recirculation of dietary nitrate is illustrated in Figure 2.1 
Nitrate is present in substantial amounts in the modern diet and is mainly 
derived from nitrogenous fertilisers (69). Intensive farming, such as the growing of 
vegetables in low light intensity but high temperature glasshouses, also leads to 
increased nitrate concentrations (70). The use of nitrogenous fertiliser began to 
increase in Western countries from the middle of the 20th century (71) leading to 
increased nitrate deposition in soil. An increase in intensive farming techniques was 
seen at the same time. Following its uptake from the soil, nitrate is reduced to the 
ammonium ion (NH4+) and then incorporated rapidly into organic compounds by the 
plant. Leaching of fertiliser subsequently leads to a gradual increase in groundwater 
nitrate concentrations. As a result, the main sources of nitrate in the human diet are 
green leafy vegetables (such as lettuce and spinach), root vegetables (such as 
beetroot and potatoes) and water. 
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In the past few decades, increasing public health concerns developed 
regarding the association between nitrate and infantile methaemoglobinaemia (72) 
and the possible association between nitrate and gastric cancer (73). This prompted 
the introduction of regulations to reduce nitrate-based fertiliser use and limit nitrate 
concentrations in food and water. In 1990, the European Commission's (EC) 
Scientific Committee for Food (SCF) set an Acceptable Daily Intake (ADI) for the 
nitrate ion of 3.65 mg/kg body weight (equivalent to 219 mg/day for a 60 kg adult) 
(74). As a result of these measures, the use of nitrogenous fertilisers has plateaued 
towards the end of the 20th century in most Western countries (75). 
 
2.2 Gastric acidification of nitrite and its carcinogenic potential 
When nitrite is swallowed it reacts with acidic gastric juice forming nitrous 
acid, the nitrosating species N2O3, NOSCN and by further reaction with ascorbic acid 
in gastric juice it is also converted to nitric oxide (NO). Nitrosating species are able to 
react with secondary amines and amides in gastric juice to form N-nitroso 
compounds (76). The endogenous production of these compounds is of interest due 
to their ability to induce cancer in animal models (77). Furthermore nitric oxide is 
itself known to be mutagenic at high doses. 
Previous work by Moriya et al (78) using a model to simulate the interaction of 
salivary nitrite and gastric acid suggested the gastro-oesophageal junction to be the 
anatomical site of maximal acid catalysed generation of N-nitroso compounds 
following a nitrate load. Subsequently, using a luminal nitric oxide sensor, Iijima et al 
(79) demonstrated maximal generation of nitric oxide at the gastro-oesophageal 
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junction in normal healthy volunteers following nitrate ingestion. Similar work by 
Suzuki et al using microdialysis probes defined the anatomical location where 
chemical conditions favouring the acid catalysed generation of N-nitroso compounds 
was maximal. In normal volunteers this occurred at the level of the gastric cardia (80) 
while in Barrett’s oesophagus, the maximal potential for nitrosation was found within 
the Barrettic segment itself (81). Therefore, in both normal volunteers and Barrett’s 
patients the anatomical location of maximal acid catalysed luminal nitrosation 
corresponds to the interface between saliva and gastric acid. Winter et al 
subsequently demonstrated the in situ formation of N-nitrosocompounds from 
ingested dietary nitrate via NO formation. During episodes of reflux this occurred 
almost exclusively in the oesophagus (82). 
These studies support the hypothesis that nitric oxide and N-nitroso 
compounds generated from salivary nitrite may be implicated directly in 
carcinogenesis at the gastro-oesophageal junction and within the distal oesophagus. 
However, they may also have a contributory role in potentiating gastro-oesophageal 
reflux disease. 
 
2.3. Salivary nitrite in the pathogenesis of GORD 
In addition to its mutagenic potential, excessive production of nitric oxide 
could explain most of the functional abnormalities associated with reflux disease. 
Nitric oxide is well recognised to induce smooth muscle relaxation, by elevation of 
tissue cyclic guanosine monophosphate (cGMP) levels (83), and a number of studies 
have described the effects of NO on upper gastrointestinal motility. 
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In vitro studies by Tottrup at al (84) on opossum lower oesophageal sphincter 
demonstrated that N-nitro-L-arginine (L-NNA) a substance known to inhibit NO 
formation inhibited lower oesophageal sphincter relaxation. This effect was 
attenuated by the NO substrate L-arginine. A similar study by Preksaitis et al (85) 
examining human lower oesophageal sphincter muscle, which also used L-NNA to 
inhibit NO, indicated that the same process was most likely involved in man. 
The effect of NO on the production of TLOSRs has also been studied. Boulant 
et al (55) described a reduction in TLOSRs induced by gastric distension in dogs 
following infusion of the NO synthase inhibitor N-nitro-L-arginine-methyl-ester (L-
NMME). Again, this effect was reversed by L-arginine. Hirsch et al (86) confirmed 
this effect on healthy, human volunteers undergoing oesophageal manometry also 
using gastric distension by balloon insufflation as the trigger for TLOSRs. L-NMMA 
or placebo was given in a randomised, double-blinded fashion and significantly 
inhibited the increase in TLOSRs brought about by gastric distension. A further study 
by Hirsch et al (87) looking at the physiological induction of TLOSRs by meal-
induced gastric distension concluded that L-NMME infusion also inhibited TLOSRs 
post-prandially and reduced the total number of reflux episodes. 
L-NMME has been found to reduce oesophageal peristalsis in animal models. 
A study by Anand et al (88) using adult opposums demonstrated a reduction in 
swallow induced contraction amplitude in the distal oesophagus following NO 
synthase inhibition. Studies in man using Sildenafil support the involvement of NO in 
oesophageal peristalsis. Sildenafil blocks type 5 phosphodiesterase (PD5) which 
destroys NO stimulated cGMP. Rhee et al (89) performed oesophageal manometry 
on healthy volunteers before and after infusion of 50mg sildenafil directly into the 
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stomach. Oesophageal body peristaltic amplitudes gradually decreased and were 
subsequently abolished with a corresponding increase in peristaltic latency. Eherer 
et al (90) confirmed this in a randomised and double-blinded study of 50mg sildenafil 
or placebo given to healthy volunteers and patients with oesophageal 
hypercontractility disorders. Reduced oesophageal body propulsive forces were 
observed in both groups. Both these studies also confirmed a reduction in LOS 
pressure following sildenafil. Similarly, increasing NO bioactivity, by inhibiting 
phosphodiesterase, enhances gastric accommodation and delays gastric emptying 
(91). 
Nitric oxide has therefore been demonstrated to lower the tone of the LOS, 
may impair oesophageal acid clearance through its effects on peristalsis, delays 
gastric emptying and is known to be the final mediator in the production of TLOSRs. 
However, can these effects be demonstrated post-prandially following an oral nitrate 
load?  
 
2.4. Previous Studies 
Bove et al (92) combined pH and manometry studies on both healthy 
volunteers and GORD patients following dietary nitrate supplementation. All 
volunteers received a nitrate deprived diet and were randomised to either potassium 
nitrate 200mg or placebo for 4 days with a two week wash-out period in between. 
They reported no significant effect on oesophageal reflux or oesophageal motility 
following nitrate supplementation. However there was a strong trend towards an 
increase in TLOSRs in the group receiving nitrate supplementation. Significantly, 
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salivary nitrite concentrations in the study were well below the levels that have 
regularly been described in studies by our own group (79). In contrast, by infusing 
nitrous acid and nitric oxide forming solutions directly into the distal oesophagus after 
a standardised meal, Manning et al (93) demonstrated that chemicals formed from 
the gastric acidification of salivary nitrite can influence oesophageal and gastric 
function which may be relevant to GORD. Using combined oesophageal pH and 
manometry studies they reported a reduction in LOS pressure and increase in 
frequency of TLOSRs post-prandially following infusion of the nitric oxide generating 
infusion. They also described an attenuation of the post-prandial increase in intra-
gastric pressure following the nitrous acid infusion, possibly due to delayed gastric 
emptying. 
 
2.5. Summary 
Human saliva has a high nitrite concentration from the entero-salivary 
recirculation of dietary nitrate. Swallowed nitrite reacts with gastric acid to form 
nitrous acid, nitrosating species and nitric oxide (NO) at the gastro-oesophageal 
junction. In addition to being potentially mutagenic and carcinogenic, this luminal 
chemistry and in particular the generation of NO, might contribute to the 
pathogenesis of reflux disease. NO has been shown to reduce lower oesophageal 
sphincter (LOS) pressure, impair oesophageal clearance, delay gastric emptying and 
may be the final mediator in the production of transient lower oesophageal sphincter 
relaxations (TLOSRs). Existing studies that examine the effect of  altering the luminal 
nitrite chemistry on gastro-oesophageal motility and whether or not this may 
potentiate gastro-oesophageal reflux show conflicting results.
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Figure 2.1. The entero-salivary recirculation of dietary nitrate (adapted from McColl KEL 
Gut 2005;54:1-3) 
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Chapter 3 
The Changing Histology of the Gastro-oesophageal Junction 
 
3.1. Oesophageal histology 
The oesophagus is lined by non-keratinized stratified squamous epithelium 
with an average thickness of 500-800µm. The basal layer consists of cuboidal or 
rectangular cells and may be several cell layers thick, also containing scattered 
melanocytes and neuroendocrine cells. Above this, epithelial cells are larger and 
become more flattened as they approach the oesophageal lumen. 
The oesophageal lamina propria is comprised of loosely arranged collagen 
fibres and fibroblasts embedded within an acellular matrix, with a scattering of 
lymphocytes, eosinophils, mast cells and plasma cells. The muscularis mucosa is of 
variable thickness, being thicker at its distal end where it approaches the GOJ. 
Mucous glands are present within the oesophageal submucosa. Each gland 
has between 2 and 5 lobes, which drain into a short duct lined by stratified columnar 
epithelium. These ducts penetrate the muscularis mucosa, lamina propria and 
epithelium to open into the oesophageal lumen, allowing secretion of bicarbonate 
and mucous which help lubricate the oesophagus and protect against acid-related 
mucosal damage. Around the glands and their ducts, lymphocytes, plasma cells and 
eosinophils can be found while the oesophageal submucosa is also rich in blood 
vessels, lymphatics and ganglion cells. 
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3.2. Gastric histology 
A key role of the gastric epithelium is to secrete hydrochloric acid and 
proteolytic enzymes to aid in the digestion of food. As a result, the gastric mucosa 
must be designed to withstand the effects of these potentially corrosive substances. 
The stomach also secretes mucous which lubricates food and helps protect the 
gastric mucosa from acid and pepsin. These secretions are produced from 3 main 
cell types: 
 Mucous cells 
 Acid-producing cells (oxyntic or parietal cells) 
 Enzyme-producing cells (Chief or peptic cells) 
 
In addition, there is a population of hormone-secreting enteroendocrine cells 
and stem cells from which other cell types are derived. 
 Gastric mucous cells are of 2 types. Surface mucous cells are tall and 
columnar. Neck mucous cells are smaller and less regular in shape, being 
compressed and distorted by adjacent cells.  
The acid-secreting parietal cells are large pyramidal cells. The capacity of the 
stomach to secrete hydrochloric acid (HCl) is linearly related to parietal cell numbers. 
Parietal cells have a vast luminal surface area as a result of deep microvilli-lined 
invaginations called canaliculi. When stimulated, parietal cells secrete HCl at a 
concentration of approximately 160 millimoles (equivalent to a pH of 0.8). Acid is 
secreted into the canaliculi by a process of active transport via the H+K+ATPase 
proton pumps located in the canalicular membrane. Hydrogen ions are generated 
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within the parietal cell from the dissociation of water. Carbon dioxide diffuses across 
the basement membrane from blood capillaries into the cell where it links with water 
molecules. This reaction, which is catalysed carbonic anhydrase, produces carbonic 
acid (H2CO3) which immediately dissociates into a H
+ ion and HCO3- ion. The latter 
passes back into the blood while the H+ is pumped into the lumen via the canaliculi. 
Chloride ions are also actively transported across the cells into the canaliculi from 
capillaries in the lamina propria. 
 
3.3. The histology of the gastric cardia 
The gastric cardia is grossly defined anatomically as the area extending 
distally from the squamo-columnar junction at the lower end of the oesophagus into 
the proximal stomach. Conventional medical teaching states that cardiac mucosa is 
normally present in humans and extends a length of 2-3 centimetres. Cardiac 
mucosa has been defined histologically as mucosa in this region composed only of 
mucous cells. It is therefore distinct from the oxyntic mucosa typically seen 
elsewhere in the stomach which contains additional parietal cells and goblet cells. 
The endoscopic appearance (A) and histology (B) of the normal gastro-oesophageal 
junction are seen in Figure 3.1. 
Cardiac mucosa is recognized as an area with a high incidence of 
inflammation, metaplasia and neoplasia. Oberg et al (94) studied patients with reflux 
symptoms or dyspepsia and found cardiac mucosa to be inflamed in 96%. Similarly 
Der et al (95) examined biopsied the cardia region in 141 patients. In all patients, 
cardiac mucosa showed significant chronic inflammation with 79% of patients 
46 
 
showing no evidence of gastritis on biopsies from the gastric antrum and body. 
Upper gastrointestinal endoscopy screening of patients attending for lower 
gastrointestinal endoscopy has also demonstrated the high prevalence of disease in 
this area. Gerson et al (96) performed upper gastrointestinal endoscopy and biopsy 
on 110 subjects attending for sigmoidoscopy as screening for colorectal cancer. In 
16% of patients, intestinal metaplasia was found at the gastric cardia. Likewise, Rex 
et al (97) examined 961 patients attending for colonoscopy and found the detection 
rate of intestinal metaplasia at the gastric cardia to be 12.9%. 
 
3.4. The ‘acquired cardia’ hypothesis 
Despite the high rate of pathology at the gastric cardia, this complex area is 
poorly understood. Indeed controversy exists as to whether cardiac mucosa itself 
may be pathological. Previous autopsy studies show a near absence of cardia 
epithelium in neonates and an increase in length with increasing age (98;99). 
Similarly, in thoroughly sampling the squamocolumnar junction of endoscopically 
normal patients, Jain et al (100) and Marsman et al (101) reported an absence of 
cardiac mucosa in 65% and 38% respectively. Furthermore, in the study by Oberg et 
al (94), of the 334 patients studied only 246 (74%) were found to have cardiac 
mucosa while 88 (26%) did not. Those with cardiac mucosa were more likely to have 
abnormal acid exposure on 24 hour pH testing and were more likely to have 
abnormalities of the LOS manometrically. They concluded this was proof that cardiac 
mucosa is in fact an abnormal structure. They suggest it originates from acid-
induced columnar metaplasia of the most distal oesophageal squamous mucosa with 
the only normal gastro-oesophageal mucosa being squamous oesophageal mucosa 
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and oxyntic gastric mucosa. It should be noted that Helicobacter-associated atrophy 
of the proximal gastric mucosa could cause a similar effect. 
Although 30-50% of upper gastrointestinal tract adenocarcinomas occur at the 
gastro-oesophageal junction (GOJ) or gastric cardia (66), unlike oesophageal 
adenocarcinoma, the association of these cancers with symptomatic gastro-
oesophageal reflux disease is weak (62). Studies using both 24 hour ambulatory pH 
monitoring and intraluminal impedance have shown a positive association between 
the  proximal extent of reflux episodes and the perception of heartburn and 
regurgitation, the cardinal symptoms of reflux disease (102-105). 
 
3.5. Distal opening of the lower oesophageal sphincter after meals 
In studies using pull through pH and manometry, our own group have 
observed post-prandial shortening of the LOS. In studies by both Manning et al (93) 
and subsequently Clarke et al (40), this shortening was found to result from a loss of 
the distal segment of the lower oesophageal sphincter (LOS) with the pH step-up 
point moving closer to or even across the squamocolumnar junction (SCJ).  
Fletcher et al had previously described an unbuffered postprandial ‘acid 
pocket’ occurring in the proximal stomach of healthy subjects after meals and 
observed that it extends across the SCJ into the distal oesophagus (39). The 
presence of a postprandial acid pocket in both healthy subjects and reflux patients 
was confirmed in the study by Clarke et al who found the ‘acid pocket’ to be located 
within the abdominal portion of the HPZ which ‘opens’ after a meal.  
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Therefore, this ‘distal opening’, which was first postulated by Oberg and 
DeMeester (94;106), may result in acidification of the most distal oesophageal 
squamous mucosa without complete loss of function of the LOS. Due to the limited 
proximal extent of acid exposure, such a process is likely to be asymptomatic and 
may explain the high incidence of pathology at the GOJ of otherwise ‘healthy’ 
subjects. 
 
3.6. Summary 
The gastric cardia and gastro-oesophageal junction is an important site of 
pathology in the gastrointestinal tract with a high incidence of inflammation, 
metaplasia and neoplasia even in asymptomatic people. It has been suggested that 
cardia mucosa itself may be pathological and represent acid-induced columnar 
metaplasia of the most distal oesophageal squamous mucosa. A possible 
mechanism for this could be distal opening of the LOS after meals in healthy 
subjects, exposing the distal oesophagus to the unbuffered post-prandial ‘acid 
pocket’. 
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Figure 3.1. The normal gastro-oesophageal junction 
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Chapter 4 
Obesity and Gastro-oesophageal Reflux Disease 
 
4.1 The global obesity epidemic 
In recent years global rates of obesity have dramatically increased, 
particularly in Western countries. As a result, healthcare systems are now dealing 
with what many describe as an epidemic of obesity and its complications, such as 
diabetes, heart disease and fatty liver disease. 
The World Health Organisation (WHO) estimates that worldwide there are 1.7 
billion people overweight (BMI ≥ 25 ≤ 30) while 300 million have a BMI >30 and 
would be classified as obese (107) according to the current WHO classification – see 
Table 4.1. 
 
4.2. A Scottish perspective 
In Scotland, a recent national survey (108) found that obesity rates have 
increased significantly over the past two decades. In adults between the ages of 16 
and 64 years old, the percentage of men who are overweight or obese has risen 
from 55.6% in 1995 to 66.3% in 2009. A similar increase, from 47.2% to 58.4%, is 
seen among women while rates of morbid obesity (BMI > 40) have trebled from 0.5% 
to 1.8% and 1.3 to 3.6% in men and women respectively between 1995 and 2009. 
Measures of central, or visceral, obesity such as waist circumference or waist-to-hip 
ratio show similar increases over this period. 
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4.3. The rising Incidence of GORD 
An increase in reflux disease has also been seen among Western populations 
over recent decades. A North American study by El-Serag et al (109) reported a four 
to seven-fold increase in presentations with reflux disease between 1970 and 1995. 
As a result, GORD is now the commonest chronic disease in Western populations. 
This raises the question of whether this increase in GORD can be explained due to 
the concomitant increase in obesity rates among the population? 
 
4.4. The epidemiological link between obesity and GORD 
Numerous studies have examined the link between obesity and GORD with 
almost all showing a significant association between obesity, measured by BMI, 
waist circumference or waist-to-hip ratio, and both the frequency and severity of 
reflux symptoms. This effect appears to be independent of differences in diet and 
exercise (110) and has been confirmed in two meta-analyses (49;111) 
The largest epidemiological study to investigate this association was 
performed by Jacobson et al (112). Using a questionnaire, the authors investigated 
the frequency, severity and duration of symptoms of GORD among 10,545 randomly 
selected participants in the Nurses’ Health Study. 2310 subjects (22%) had weekly 
symptoms of heartburn, acid regurgitation or both. They observed a dose-dependent 
relationship between increasing BMI and frequent reflux symptoms. Similar findings 
were documented when waist circumference was examined. Furthermore, in the 
group with a normal baseline BMI, an increase in BMI of greater than 3.5 was 
associated with an increased risk of frequent reflux symptoms (OR 2.8) when 
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compared with no weight gain. These results support the hypothesis that obesity 
increases the risk of GORD and suggest that even moderate weight gain in subjects 
of normal weight may cause or exacerbate reflux symptoms. 
In the United Kingdom, similar work by Murray et al (113) studied 10,537 adult 
subjects as part of the Bristol Helicobacter Project. They confirmed this association 
in our own population, finding that overweight subjects were at increased risk of 
suffering GORD symptoms. The adjusted odds ratios for overweight subjects of 
suffering symptoms of heartburn and regurgitation were 1.82 and 1.5 respectively 
while the corresponding OR for obese subjects were 2.91 and 2.23. 
The risk of reflux oesophagitis is also increased in overweight and obese 
subjects. In a study of 1224 Scandinavian patients referred for upper GI endoscopy, 
Stene-Larsen et al found that obesity, measured using the weight for height index, 
was associated with an increased risk of reflux oesophagitis (114). Following on from 
this, El-Serag et al found that obesity was an independent risk factor for severe (Los 
Angeles Grade C or D) oesophagitis with an OR of 1.21 (115). 
These results clearly suggest an increased risk of both GORD symptoms and 
clinical manifestations in overweight and obese adults. 
An interesting addition to the current evidence supporting this association is a 
randomised trial by Fletcher et al from our own group (116). In this study, which 
examines factors predicting response to proton pump inhibitor (PPI) therapy, 105 
Helicobacter Pylori negative subjects with upper gastrointestinal symptoms but 
normal endoscopy were randomised to two weeks of treatment with PPI or placebo. 
Symptom severity scores were calculated before and during treatment with PPI or 
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placebo. Anthropometric measurements, 24 hour oesophageal pH studies and 
oesophageal manometry were also performed prior to randomisation. The 
investigators found that the only non-invasive predictor of response to PPI treatment 
was a patient’s BMI. The BMI was noted to have a similar predictive value to 24h 
oesophageal pH or manometry suggesting a strong association between BMI and 
underlying reflux disease. 
 
4.5. Mechanisms by which obesity may precipitate GORD 
The epidemiological data clearly points to a significant positive association 
between obesity and GORD but if this is true, how does obesity lead to GORD? 
A host of dietary and lifestyle factors relating to obesity share a common link 
to GORD but the effect of obesity has been shown to be independent of diet and 
exercise. It was previously suggested that obese patients may have a greater 
volume of acidic stomach contents than their leaner counterparts thus increasing the 
potential for harmful reflux. However, a study by Harter et al showed that, in fact, the 
opposite holds true with obese patients having a lower volume of gastric contents 
and a higher pH (117). Similarly, gastric acid secretion has actually been found to be 
lower in morbidly obese patients (118). 
Despite this, there is good evidence that oesophageal acid exposure is 
increased in obese subjects. El-Serag et al and Cowell et al have both studied the 
effects of obesity on oesophageal acid exposure using conventional catheter-based 
24 hour pH monitoring and 48 hour wireless capsule pH-metry respectively. In the 
first study, El Serag et al found that both increased BMI and waist circumference 
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were associated with a significant increase in reflux events, long reflux events 
(>5mins), time pH<4 and DeMeester Score (119). Subsequently Crowell et al 
confirmed these results over the more prolonged monitoring period, showing an 
increase in total acid exposure time and DeMeester scores in the obese subject 
group (120). 
It has traditionally been postulated that obesity increases the mechanical 
stresses on the gastro-oesophageal junction. Increased abdominal girth could result 
in increased intra-abdominal pressure which in turn could promote gastro-
oesophageal reflux by increasing intragastric pressure. Increased intragastric 
pressure potentially increases retrograde flow across the gastro-oesophageal 
junction by overcoming the lower oesophageal high pressure zone. However, as 
already described, the pathophysiology of GORD is multi-factorial and complex. As 
such, many possible mechanistic hypotheses exist to explain the role of obesity in 
reflux disease. 
Increased intragastric pressure has been described in obese subjects. This 
results in an increase in the gastro-oesophageal pressure gradient (GOPG) in line 
with the traditional hypothesis above (121;122). However, in obesity, several 
morphological changes in the gastro-oesophageal junction have also been 
described. Since the GOJ provides the most important anti-reflux barrier, any change 
which results in a weakening of this barrier is likely to be important in the 
pathogenesis of reflux. Lower resting LOS pressure and shortening of the LOS 
length have been described in obesity (123). It has been suggested that the 
increased GOPG that exists in obesity may promote the development of hiatus 
hernia. Certainly several studies show a significant positive relationship between 
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obesity and the presence of a hiatus hernia, with an overall prevalence of 40% in 
obesity versus 12.6% in the general population (124). The association of hiatus 
hernia with GORD and oesophagitis is well described (33). Finally, Wu et al have 
previously demonstrated an association between obesity and post-prandial TLOSRs, 
the primary mechanism of reflux in patients with normal resting LOS pressure (125). 
Contradictory evidence exists regarding the effect of weight loss on reflux 
disease. Studies by Fraser-Moodie et al (126) and Jacobson et al (112) both 
demonstrated a reduction in reflux symptoms with weight loss. Kjellin et al (127) 
studied the effects of weight loss on clinical and physiological correlates of reflux. 
Conversely, they found no effect on symptoms of GORD, pH or manometry. If weight 
loss does not reduce GORD, this could be explained by the hypothesis that obesity, 
through a subsequent increase in the GOPG, provokes the development of a hiatus 
hernia. This may be due to axial pressure strain through the phreno-oesophageal 
ligaments and crural diaphragm. Once a hiatus hernia has developed, the alteration 
in GOJ morphology and associated predisposition to reflux may be permanent 
regardless of weight loss. 
 
4.6. Obesity and Barrett’s oesophagus 
Barrett’s oesophagus, the metaplastic change in oesophageal mucosa from 
its usual squamous epithelial lining to a specialized columnar epithelium, occurs due 
to chronic reflux and is recognised as a strong risk factor for oesophageal 
adenocarcinoma. A number of recent studies show an association between obesity 
and the risk of Barrett’s oesophagus. A retrospective cross-sectional study by Stein 
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et al (128) looked at 65 cases of Barrett’s oesophagus compared with 385 controls. 
The risk of Barrett’s oesophagus was increased approximately 2.5 times in subjects 
who were overweight or obese. While these results may be expected given the 
association between obesity and increased reflux, a study by Smith et al (129) 
suggests that it may not simply be by promoting acid reflux that obesity influences 
the development of Barrett’s oesophagus. They performed a population-based case-
control study of 167 Barrett’s patients and 261 age and sex-matched controls, finding 
that obese subjects with reflux symptoms had a markedly higher risk of Barrett’s 
oesophagus (OR 34.4) than subjects with reflux (9.3) or obesity (0.7) alone. 
 
4.7. Male sex, visceral obesity, Barrett’s oesophagus and adenocarcinoma of 
the oesophagus and GOJ 
It is recognised that Barrett’s oesophagus (130) and oesophageal 
adenocarcinoma (65) are significantly more common in males. A number of possible 
explanations for this gender difference exist. Barrett’s oesophagus and oesophageal 
adenocarcinoma both arise from a background of chronic inflammation and mucosal 
damage. Oestrogen, has been shown to suppress the inflammatory response and 
cytokine production (131;132). Similarly, females have lower iron stores during their 
reproductive years which might modify the degree of DNA damage arising from 
chronic inflammation.  
Gender differences are also well recognized in the distribution and type of 
adipose tissue. For any given body mass index (BMI), body composition differs 
between the sexes. Men have a higher lean mass while in women there is more 
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adiposity (133). Furthermore, the distribution of fat in males tends to be more central 
but predominantly peripheral in females. This altered fat distribution has been 
demonstrated using magnetic resonance imaging (MRI) and computerized 
tomography (CT) to correspond with greater visceral adipose tissue (VAT) and less 
subcutaneous adipose tissue (SAT) in men compared with women (134;135). 
Similarly, greater VAT is found in caucasian versus non-caucasian populations 
(136).  
A higher risk of Barrett’s oesophagus and oesophageal adenocarcinoma is 
seen in white males, in whom central (visceral) obesity predominates. Studies using 
CT measurement of visceral adiposity support the association between central 
obesity and both Barrett’s oesophagus and oesophageal adenocarcinoma. 
Fat distribution may act through a mechanical effect promoting the 
development of gastro-oesophageal reflux with a subsequent increased risk of 
Barrett’s oesophagus and oesophageal adenocarcinoma. Alternatively, visceral 
adipose tissue is well recognised to be more metabolically active and secretes a 
variety of biological substances which may be pro-inflammatory and promote 
tumourigenesis (107). Potential mediators of carcinogenesis in obesity and biological 
pathways which have been implicated as contributory are listed in Table 4.2.  
A number of possible mechanisms of tumourigenesis have also been 
described. Altered metabolism and increased production of sex hormones and 
glucocorticoids occurs in obesity (137). The resulting increases in insulin resistance 
induce compensatory hyperinsulinaemia with increased production of insulin-like 
growth factor 1. Increased cellular proliferation and impaired apoptosis may result, 
increasing the risk of metaplasia and neoplasia (138). Alternatively, Leptin may 
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stimulate tumour cell growth, migration and invasion as well as enhancing 
angiogenesis (139). 
It is estimated that approximately 40% of patients with oesophageal 
adenocarcinoma have developed the disease due to being overweight or obese 
(140). Several large prospective epidemiological studies have demonstrated an 
increased risk of oesophageal adenocarcinoma and gastric cardia adenocarcinoma 
with increasing BMI (141-143). The strong positive relationship between obesity and 
these cancers persists when adjusted for meal size and physical activity (144) and 
obesity has also been found to be associated with the development of these cancers 
at an earlier age. Corley et al (145), using a nested case-control study design, have 
shown that increasing waist circumference is associated with an increased risk of 
oesophageal adenocarcinoma, independent of BMI. This data again supports a 
strong association between the risk of oesophageal adenocarcinoma and visceral 
obesity. 
 
4.8. Obesity and the distal opening hypothesis 
As previously discussed, 30-50% of upper gastrointestinal cancers occur at 
the GOJ, often in otherwise asymptomatic patients. Distal opening of the LOS after 
meals could expose the distal oesophageal squamous mucosa to the harmful and 
potentially carcinogenic effects of acidic reflux.  
Previous studies in respiratory medicine have demonstrated that the 
diaphragm moves proximally in obesity, particularly when lying flat (146-149). 
Therefore, the migration of the squamous oesophageal lining into the stomach may 
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be more pronounced with increasing body mass index (BMI). This ‘distal opening’ 
may help to explain the increasing incidence of gastro-oesophageal junction cancers 
in western countries where there is also a trend to increasing BMI. 
 
4.9. Summary 
Western countries are currently experiencing an obesity epidemic. At the 
same time, gastro-oesophageal reflux disease and its complications are becoming 
more common in these populations. Clear links exist between symptomatic GORD, 
Barrett’s oesophagus and oesophageal adenocarcinoma. Furthermore, obesity could 
theoretically exacerbate distal opening of the LOS with resultant acidification of the 
distal oesophageal squamous mucosa leading to acid-induced inflammation, 
metaplasia and ultimately neoplasia. 
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Table 4.1 WHO BMI Classification 
Classification BMI (kg/m2) 
Underweight <18.5 
Normal ≥18.5 and <25 
Overweight ≥25 and <30 
Obese ≥30 
 
Table 4.2. Potential mediators and pathways implicated the role of obesity in 
tumourigenesis 
Mediator Pathways 
Adipokines Complement Activation 
Cytokines Renin Angiotensin System 
Tumour Necrosis Factor α (TNFα) Altered Glucocorticoid Metabolism 
Insulin Altered Sex Hormone Metabolism 
Plasminogen Activator Inhibitor 1  
Resistin  
Leptin  
Adiponectin  
Vascular Endothelial Growth Factor (VEGF)  
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Chapter 5 
Research Aims and Methods 
 
5.1. Research Aims 
The aim of this series of experiments was to further investigate, in normal 
human subjects, the basic pathogenesis of gastro-oesophageal reflux and 
oesophageal columnar metaplasia.  
In particular: 
i. to examine the effect of nitrite delivered in saliva, and the associated 
luminal nitric oxide produced on reaction with acid at the gastro-
oesophageal junction, on gastro-oesophageal function.  
ii. to investigate anatomical and physiological changes at the GOJ 
following a meal 
iii. to investigate the effect of age and obesity on the GOJ 
 
5.2. Methods 
 
5.2.1. Upper gastrointestinal endoscopy 
Prior to the first study day, the participant attended fasted for an endoscopy. 
This was carried out using topical anaesthesia with xylocaine local anaesthetic 
spray. The anatomy of the upper gastrointestinal tract was documented. Biopsies 
were taken from both gastric antrum and body for rapid urease CLO test to 
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document Helicobacter Pylori status. Endoscopy was carried out a minimum of one 
day before the first study day.  
 
5.2.2. pH studies 
All pH studies were performed using a specially designed antimony 12 sensor 
high-resolution pH catheter (Synectics Medical Ltd, Enfield, UK) as previously 
described (150). The catheter was 2.1 mm in diameter, flexible and had 12 
electrodes along its distal end with an external reference electrode for application to 
the upper arm – see Figure 5.1. The most distal pH electrode was located at the tip 
of the catheter and the other 11 electrodes were 30, 50, 61, 72, 83, 94, 105, 116, 
127, 138 and 172 mm proximal to it – see Figure 5.2. Prior to nasal intubation, 
individual electrodes were calibrated in buffer pH 1.07 and 7.01. Data was collected 
and analysed using PolygramNet® software (Medtronic Inc., Fridley, Minnesota, 
USA) and was exported and processed using our own custom-designed software for 
further detailed analysis. 
 
5.2.3. High-resolution manometry studies 
Manometry was performed using a solid-state high-resolution manometry 
assembly (Manoscan®, Sierra Scientific Instruments Inc., Los Angeles, California, 
USA). The catheter comprises 36 circumferential pressure sensing elements spaced 
at 1cm intervals – see Figure 5.3. Each sensing element incorporates 12 radially 
dispersed pressure sensors able to detect pressure over a length of 2.5mm. Sector 
pressures are averaged to provide a circumferential pressure reading. The system 
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was calibrated to 0 and 300mmHg using externally applied pressure prior to use. 
Furthermore in vivo calibration was performed at body temperature (36-38°C). 
Immediately after extubation, while sensing-elements remained at body temperature 
and were exposed to atmospheric pressure a time for thermal re-calibration was 
selected. To correct for thermal drift, a change in measured pressure due to change 
in temperature, a linear correction from 0mmHg was applied to the exported 
manometry data. Robertson et al, from our own group, have previously characterized 
the thermal drift which occurs in prolonged studies using the Manoscan® high-
resolution manometry (151). They have shown this to be a linear phenomenon and 
the above correction process significantly improves the accuracy of recordings using 
this system. 
Manometry studies were analysed using specialized analysis software 
(Manoview®, Sierra Scientifics) – an example of a normal swallow viewed using the 
Manoview® analysis software is shown in Figure 5.4. In addition to this, manometric 
data was exported and processed using our own custom-designed software for 
further detailed analysis. 
 
5.2.4. Combined pH and manometry apparatus 
pH and manometry apparatus was attached using adhesive tape with pH 
sensor 7 adjacent to manometry sensor 29 – see Figures 5.5. and 5.6. This allowed 
accurate comparison of pH and manometry. The combined apparatus was passed 
per nasally and attached at the nose using adhesive tape. pH and manometry 
studies were synchronized electronically. 
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5.2.5. Data processing 
Our pH and manometry studies were synchronized electronically by starting 
both recordings simultaneously. For all studies the raw manometry and pH data was 
extracted as text files from the Manoscan® and PolygramNet® software respectively. 
The 36 channel Manoscan® system records manometry data at a frequency of 40Hz 
while our high-resolution pH catheter records 8 readings per second for each of the 
12 sensors (8Hz). Therefore, for a study consisting of 15 minute fasting data and 90 
minute post-prandial data this generates 9,676,800 individual data points. The 
synchronized pH and manometry data was combined using our custom-designed 
‘ManpH’ software. This allowed us to compress the manometry data into 8 readings 
per second allowing direct comparison with the pH data. To do this the mean of the 
manometry recordings taken over each 0.125s was calculated from the raw data. 
This reduced to 2,419,200 the number of individual data points. It also allowed 
selection of specific time periods and provided text files that could be exported into 
Microsoft Office Excel 2007 (Microsoft®, Redmond, Washington, USA) for further 
analysis. 
 
5.2.6. Nitrite solutions 
Nitrite solutions were pre-prepared as potassium nitrite by the Pharmacy 
Production Unit, Western Infirmary, Glasgow. Solutions were labelled A-D with the 
researcher blinded to the concentration of each solution until data analysis had been 
performed. Stock solutions were regularly monitored for stability of nitrite 
concentrations, again the researcher was blinded to these results. 
67 
 
The concentrations of potassium nitrite were 0, 0.286, 2 and 14mmol/l – 
details of the nitrite solutions are shown in Table 5.1. Each solution also contained 
1mmol/l Potassium Thiocyanate. Thiocyanate is normally present at this 
concentration in non-stimulated saliva but levels have been found to be lower in 
studies involving orogastric tube insertion and with increased salivary flow 
rates.(80;152) Solutions were prepared to a pH expected of normal saliva (pH 6.12 – 
6.38).  
Concentration of nitrite in saliva in the fasting state ranges between 50 and 
600µmol/l and rises several fold following ingestion of nitrate in the diet (79). The 
concentration of nitrite used in our highest dose was greater than that occurring in 
swallowed saliva after a nitrate–rich meal. It is equivalent to the total nitrite load in 
the study by Manning et al which demonstrated an increase in post-prandial TLOSRs 
following infusion of a NO-generating solution into the gastric cardia (93). 
In normal circumstances, the minimal total unstimulated salivary flow rate is 
defined as 0.1 ml per minute, and the minimal stimulated flow rate is 0.2 ml per 
minute. Maximal stimulated flow rate is 7 ml per minute. The 24-hour volume of 
salivary secretion has been estimated to be 500 to 1,500 ml, or an average flow of 1 
ml per minute. 
Table 5.2. shows the estimated potassium concentrations of saliva and gastric 
secretions compared with our solutions over the 90 minute study period. The 
maximum safe nitrite dose for a healthy volunteer has been estimated by the World 
Health Organisation (WHO) as between 290 - 370 mg of nitrite (153). The maximum 
cumulative nitrite dose used in our study, over all 4 study days, was less than 20% of 
this value at 50.57mg. 
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5.2.7. Controlling for variability in dietary nitrate intake 
To control for variability in dietary nitrate intake volunteers were instructed 
regarding measures to reduce their endogenous salivary nitrite content in the 24 
hours prior to each study day. This included avoiding foods recognised as having a 
high nitrate concentration, such as salads and green leafy vegetables, as well as the 
twice daily use of 0.2% chlorhexidine antibacterial mouthwash. Antibacterial 
mouthwash has been shown to reduce salivary nitrite concentrations by reducing 
bacterial reduction of salivary nitrate to nitrite.(154)  
 
5.2.8. Intra-oral nitrite delivery 
On each of the nitrite study days, the volunteers’ salivary nitrite concentrations 
were modified to a different level post-prandially by intra-oral infusion of potassium 
nitrite solutions. Following consumption of our standardised meal, a fine bore (1mm) 
catheter (Vygon (United Kingdom) Ltd, Cirencester, Gloucestershire, United 
Kingdom) perforated at its distal end, was placed in the mouth for infusion of test 
solutions to modify salivary nitrite concentration – see Figure 5.7. Solutions were 
infused over 90 minutes at a rate of 0.5ml per minute. 
 
5.2.9. Quantification of salivary nitrite concentration 
Immediately after sampling, 1ml of saliva was mixed with 50µl of 1mmol/l 
NaOH. This rendered the sample alkaline, preventing nitrite being converted to nitric 
acid and lost. Samples were stored at 4ºC, then centrifuged on the same day at 
3000 rpm for 10 minutes. 250µl aliquots were subsequently removed from the 
supernatant. These were frozen at -20ºC for later analysis. Analysis of thawed 
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samples was performed on 96-well microplates using a modified Griess reaction. 
Colorimetric analysis was performed 30 minutes after the addition of the Griess 
reagents using a 540nm filter. Analysis was performed at CBP laboratories, Western 
Infirmary and results blinded to researcher until after data analysis was complete. 
 
5.2.10. X-ray screening 
X-ray screening of the gastro-oesophageal junction was carried out during 
normal respiration using a portable C-arm fluoroscope (Philips BV Pulsera). 
Screening was performed both in the fasting state and following the meal for 
approximately 30 seconds and synchronized with pH manometry recordings using 
an event marker. Images were recorded using a digital video recorder (JVC SR-
DVM600E). Further analysis was performed using image analysis software (Scion 
Image, Scion Corporation, Frederick, Maryland, USA). The position of the clip 
relative to the pH and manometry catheters was calculated with the measured 
distance of one pH sensor (known to be 1cm) used as an internal scale. An example 
of an X-ray screening still obtained during the study is shown in Figure 5.8. 
 
5.3. Statistical Analysis 
Statistical analysis was performed using MiniTab version 16 (Minitab, State 
College, PA, USA) or SPSS version 18 (IBM, New York, NY, USA) statistical 
software. 
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Table 5.1 Details of nitrite solutions 
Nitrite Concentration 
(mmol/l) 
Total Nitrite Load (µmol) Randomisation 
0 0 B 
0.26 12.87 C 
2 90 A 
14 630 D 
 
Table 5.2 Estimated electrolyte levels in stimulated saliva and post-prandial secretions 
and comparison with nitrite solutions 
Electrolyte 
Range in normal  
stimulated saliva 
(mg)* 
Range in post-
prandial gastric 
secretions (mg) † 
Maximum present in 
solutions infused 
(mg) 
Potassium 35.2 -105.6 71.0 – 699.6 26.56 
 
*Calculated from stimulated saliva flow rate of 1ml/min = 90ml over study period 
†Calculated from estimated 90-minute post-prandial gastric secretion volume of 506.9ml 
(155) 
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Figure 5.1. 12-sensor pH catheter 
 
 
 
Figure 5.2. pH catheter sensor spacing 
 
 
 
Figure 5.3. Manoscan® 36-sensor high-resolution manometer 
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Figure 5.4. Manoview® analysis software – normal swallow 
 
 
 
Figure 5.5. Combined pH manometry apparatus 
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Figure 5.6. Combined pH manometry apparatus alignment 
 
 
 
Figure 5.7. Intra-oral nitrite infusion catheter 
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Figure 5.8. Fluoroscopic screening image 
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Chapter 6  
The Effect of Nitrite in Saliva on Gastro-oesophageal Reflux 
 
6.1. Introduction 
Human saliva has a high nitrite concentration from the entero-salivary 
recirculation of dietary nitrate. Swallowed nitrite reacts with gastric acid to form nitric 
oxide (NO) at the gastro-oesophageal junction. This may contribute to the 
pathogenesis of reflux disease. NO has been shown to reduce lower oesophageal 
sphincter (LOS) pressure, impair oesophageal clearance and may be the final 
mediator in the production of transient lower oesophageal sphincter relaxations 
(TLOSRs). 
 
6.2. Aims 
The aims of this study were: 
i. to determine whether nitrite in swallowed saliva increases oesophageal 
acid exposure 
ii. to establish whether nitrite in swallowed saliva modifies the manometric 
characteristics of the lower oesophageal sphincter 
iii. to examine how any of these effects relate to the range of nitrite 
present  in human saliva.      
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6.3. Subjects 
Twenty-five non-smoking healthy subjects were recruited. In 2 subjects we 
were unable to pass the pH manometry apparatus per nasally while a further 3 
subjects withdrew due to discomfort during the procedure. 20 subjects (11 male) 
completed the full study protocol with a mean age of 30.8 years (Range 19 – 59). 
The baseline characteristics of our study population are shown in Table 6.1. 
 
6.4. Methods 
  The subjects underwent studies of gastro-oesophageal function on 4 separate 
days with their saliva nitrite concentration modified to a different level on each of the 
days. The study day outline is illustrated in Figure 6.1. Two days prior to the first 
study day, upper gastrointestinal (GI) endoscopy was performed in order to 
document the anatomy of their upper GI tract.  Antral and body biopsies were taken 
for H. pylori rapid urease test. 
On each of the four study days, subjects reported fasted at 0900h and a 
combined high resolution solid state manometer probe and high resolution pH 
catheter were passed per nasally to allow detailed continuous recording of pressure 
and pH throughout the oesophagus, gastro-oesophageal junction and proximal 
stomach.  The high resolution manometer has 36 pressure sensors 1cm apart and 
records the pressure at each site 40 times per second as previously described (156). 
The custom-made pH catheter has 12 antimony sensors, with the nine electrodes in 
the region of the squamocolumnar junction 11 mm apart, and records the pH at each 
site eight times per second as previously described (150).  A fine bore (1mm) 
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catheter was placed in the mouth and secured to the teeth for infusion of test 
solutions into the mouth to modify salivary nitrite concentration.  The studies were 
performed with the patients sitting semi-upright. 
  After recording pH and manometry over a 15 min fasting period, the subjects 
consumed a standardized meal over 20 minutes and the pH and manometer 
recordings continued for a further 90 minutes.  The meal consisted of two fishcakes 
and one rolled oats flapjack with 150ml water.  (Total calorie content = 526.35kcal).  
Infusions of the test solutions (0.5ml/min) into the mouth commenced immediately 
after completion of the meal and continued throughout the 90min postprandial 
recording period.  The buccal infusions were given in randomised double blind 
fashion containing 0, 0.286, 2 or 14 mmol/l potassium nitrite on the four separate 
study days.  All participants were instructed regarding measures to reduce their 
endogenous salivary nitrite content over the 48 hours prior to each test.   This 
consisted of avoiding high nitrate containing foods and twice daily use of 
chlorhexidine antibacterial mouth wash.  Samples of saliva were obtained for 
determining the actual nitrite concentration during the fasting period and at 30 minute 
intervals following the commencement of the nitrite infusion on each study day.  The 
concentrations were not revealed until all the data were complete. 
Blood pressure and pulse rate were recorded on each study day prior to and 
following completion of the nitrite infusion. 
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6.5. Analysis  
6.5.1 Oesophageal acid exposure 
Acid exposure was calculated as %time pH<4 and recorded both at 5 - 6cm 
(traditional reflux) and 1 - 2cm (short-segment reflux) proximal to the fasting pH step-
up point.  Individual reflux episodes were identified using PolygramNet® software 
(Medtronic Inc., Fridley, Minnesota, USA). These were defined at 5-6cm according to 
the following criteria; i) pH fall to <4 with a minimum pH fall of 1 unit, ii) a minimum 
duration of event of 3 seconds and iii) a minimum interval of 10 seconds between 
events (157). The duration (in seconds) and nadir pH of each reflux event was also 
recorded.  
 
6.5.2. Manometry of the lower oesophageal sphincter 
Transient Lower oesophageal Sphincter Relaxations (TLOSRs) were 
identified using the Manoview analysis software and defined according to the 
Holloway criteria (20) which is detailed in Table 6.2. 
For more detailed analysis, the 15 minute period immediately before the meal 
and the 6 consecutive 15 minute periods after the meal were identified. During the 
last 10 minutes of each period, 6 inspiratory and 6 end-expiratory points were 
selected using a custom-made computer programme. The lower border of the LOS 
was defined as the most distal position where the pressure rose to > 2mmHg above 
gastric baseline. Similarly, the upper border of the LOS was defined by a fall in 
pressure to within 2mmHg of intragastric pressure. The expiratory and inspiratory 
pressures were defined as the highest recorded pressures within the LOS at each 
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time-point. The respiratory inversion point (RIP) was defined as the point at which 
the manometry pressure wave decreases on inspiration. Total LOS length, intra-
thoracic sphincter length and intra-abdominal sphincter length were calculated in 
expiration. 
To evaluate oesophageal peristalsis, using the Manoview® analysis software, 
a single completed swallow was identified from each of the 9 consecutive 10 minute 
periods following completion of the meal. The mean peristaltic wave velocity was 
calculated using measurements from 9cm and 5cm proximal to the mid-point of the 
lower oesophageal high pressure zone (HPZ). Mean onset velocity (cm/s) was 
calculated between 13cm and 5cm proximal to the mid-point of the high pressure 
zone. 
 
6.5.3. Intragastric pressure 
Intragastric pressure was defined, relative to atmospheric pressure, as the 
median pressure in the 3 sensors immediately distal to the LOS. 
 
6.6. Power calculations 
The primary outcome was oesophageal acid exposure.  Calculations indicated 
that recruiting 20 subjects would have power to detect a doubling (100% change) in 
values.  This assumes standard deviation of the percentage change in oesophageal 
acid exposure to be 105 and utilizes a significance level of 1% to account for the 
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multiple comparisons that will be made with a two-sided test.  The standard deviation 
of the percentage change was derived from published data (158).  
 
6.7. Statistical analysis 
All results are given as medians and interquartile ranges unless otherwise 
stated. The Wilcoxon signed-rank test was used to analyse the effect of the meal on 
the control day. To test the changes of variables against different nitrite solutions, the 
nonparametric Friedman’s test or Kruskal-Wallis test were used. The Wilcoxon-
signed rank test or Mann-Whitney U test was used as post-hoc test in case of a 
significant (p value < 0.05) result of the Friedman’s or Kruskal-Wallis tests. 
 
6.8. Ethics 
The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant.  
 
6.9. Results 
Of the 25 healthy volunteers recruited, 5 could not tolerate the nasal 
intubations and withdrew from the study.  Twenty (11 male, mean age 30.8 years, 
range 19-59; 18 H. pylori negative) completed the full study protocol.   
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6.9.1. Effect of the meal on gastro-oesophageal function on the control day 
We and others have reported previously that changes occur in the gastro-
oesophageal junction in response to a meal.  These include (i) increased 
oesophageal acid exposure, (ii) increased frequency of TLOSRs, (iii) reduction in 
peak LOS pressure and (iv) reduction in overall LOS length due to loss of pressure 
in its most distal component (40;93). In order to confirm the validity of our recording 
equipment and experimental set-up, we analysed data obtained on the control 
infusion day to ensure that the expected changes were recorded in response to the 
meal. Manometry data obtained over the 15 minute initial fasting period was 
compared with that over each six consecutive 15 min periods after commencement 
of the standardised meal. Results and p values are displayed in Table 6.3. 
 
6.9.1.a. Oesophageal acid exposure 
In the conventionally positioned sensor (5 - 6cm above fasting pH step-up 
point) the median percentage time oesophageal pH < 4 increased from 0% (0 - 1.89) 
during fasting to 0.49% (0 - 19.96) post-prandially (p=0.002). Similarly at the sensor 
located 1 - 2cm above the fasting pH step-up point, acid exposure increased 
significantly after the meal from 1.21% (0 – 7.75) fasting to 6.01% (0.89 – 74.36) 
post-prandially (p<0.001). These results are illustrated in Figure 6.2. 
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6.9.1.b. Lower oesophageal sphincter  
There was an increase in the rate of TLOSRs following the meal from 0/hour 
(0 - 4) during fasting to 7.3 (4 - 11.3) post-prandially (p<0.001) – see Figure 6.3. 
Expiratory LOS pressure was reduced following the meal from 29.37mmHg (11.83 – 
51.19) to 19.18mHg (8.18 – 34.53; p=0.001) relative to atmospheric pressure and 
from 17.29mmHg (4.9 – 37.76) to 12.04mmHg (4 – 23.79; p<0.001) relative to 
intragastric pressure. Inspiratory LOS pressure was also reduced from 39.47mmHg 
(16.9 – 60.17) to 30.42mmHg (14.45 – 53.09; p=0.02) relative to atmospheric 
pressure and 25.35mmHg (10.11 – 43.9) to 18.13mmHg (6.50 – 40.25; p=0.035) 
relative to IGP. 
Although the absolute reduction in LOS pressure following the meal was 
similar in both expiration and inspiration, proportionally, the post-prandial fall in 
expiratory LOS pressure was greater than the reduction in inspiratory LOS pressure 
relative to both atmospheric pressure and IGP. The post-prandial reductions in 
expiratory LOS pressure and inspiratory LOS pressure, relative to atmospheric 
pressure, were 27.92% (-9.15 – 71.76) and 22.67% (-139.86 – 59.3; p=0.005) 
respectively. Similarly, when taken relative to intragastric pressure, the end-
expiratory reduction in LOS pressure was greater, being 39.66% (-30.74 – 78.8) 
versus a reduction in the inspiratory LOS pressure of 33.3% (-185.1-63.9; p=0.004). 
The result for each individual 15 minute post-prandial period is displayed in Figure 
6.4. 
Following the meal there was significant shortening of the LOS length, from 
5cm (3 – 6cm) to 4cm (1 – 6cm; p=0.001) during expiration, due to loss of the distal 
component of the LOS. While intrathoracic length was unchanged, median difference 
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0cm (-1 – 2), intra-abdominal sphincter length was reduced, median difference 1cm 
(0 – 2; p<0.001) – see Figures 6.5 – 6.7. 
 
6.9.1.c. Intragastric pressure   
There was a trend towards a reduction in intragastric pressure following the 
meal. Inspiratory IGP fell from 11.99 (6.02 – 20.02) fasting to 10.25 (9.52 – 
21.79;p=0.059) after the meal. Expiratory IGP fell from 10.51mmHg (4.15 – 19.07) 
fasting to 8.93mmHg (3.22 – 20.4: p=0.089) after the meal. These results are shown 
in Figure 6.8.   
 
6.9.3. Effect of alteration in salivary nitrite on gastro-oesophageal function  
 The analysis of salivary nitrite demonstrated that there was a significant 
difference in the salivary nitrite concentrations on each of the four study days.  At 60 
minutes following the meal the concentrations of salivary nitrite recorded were 
24.3µmol/l (3.8 – 65.4), 80.4µmol/l (20.8 – 158.7), 372.8µmol/l (118.2 – 726.6) and 
2398.5µmol/l (600 – 8087) for the solutions containing 0mmol/l, 0.286mmol/l, 
2mmol/l and 14mmol/l potassium nitrite respectively. The difference in salivary nitrite 
concentrations at 60 minutes is shown in Figure 6.9. 
 To save space in presenting results, the four different study days will be 
referred to as 1, 2, 3, 4 with one being the lowest nitrite concentration (control) and 4 
the highest. Results and p values are displayed in Table 6.4. 
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6.9.2.a Oesophageal acid exposure 
The percentage time pH<4 at 5-6cm above the fasting pH step-up point during 
the 90 min postprandial period was similar on each study day, being 0.43 (0 - 19.96), 
1.09 (0 - 35.8), 1.02 (0 - 28.09) and 0.57 (0 - 31.45) on days 1-4 respectively – see 
Figure 6.10.  At 1-2cm above fasting pH step-up point, the corresponding values 
were also not different from each other, being 6.01 (0.84 – 74.36), 6.38 (0.81 – 
86.63), 9.67 (0.02 – 93.2) and 5.72 (0.08 – 68.64) – see Figure 6.11.  The number of 
reflux events was also similar on each study day being 2.5 (0 – 11), 5 (0 – 16), 4 (0 – 
17) and 2.5 (0 – 13) for study days 1-4 respectively– see Figure 6.12.  Duration of 
reflux events was also similar being 12.81 seconds (3.09 - 264.12), 14.98 seconds 
(3.24 – 301.15), 17.65 seconds (3.08 – 353.31) and 13.34 seconds (3.11 – 473.4) – 
see Figure 6.13. 
 
6.9.2.b. Lower oesophageal sphincter function 
 There was no difference in the number of TLOSRs recorded during the 90 
minute postprandial period between the different study days being 11 (6 - 17), 13 (6 - 
17), 12 (6 - 17) and 12 (7 - 18) for solutions 1-4 respectively – see Figure 6.14.   
Peak expiratory LOS pressure decreased following the meal on each study 
day relative to both atmospheric and intragastric pressure. Comparing the fasting 
and postprandial values for each individual showed that the change in LOS pressure 
following the meal was similar on each of the study days, being –8.03mmHg (-26.12 
– 2.08), -7.83mmHg (-37.56 – 7.72), -5.67mmHg (-42.37 – 12.82) and -8.33mmHg (-
55.57 – 4.13) relative to atmospheric pressure and  -7.14mmHg (-22.9 – 3.15), -
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4.88mmHg (-37.04 – 5.75); -6.76mmHg (-42.08 – 14.7) and  -8.54mmHg (-51.83 – 
2.15) relative to IGP for solutions 1-4 respectively. 
The changes in the lower oesophageal sphincter profile following the meal 
were similar on each study day including total length, intra-thoracic sphincter length 
and intra-abdominal sphincter length. 
 
6.9.2.c. Oesophageal peristalsis 
There was no difference in the peristaltic wave amplitude during the 90 min 
postprandial period on the four study days being 36.5mmHg (18.5 – 98.7), 
33.5mmHg (19.4 – 83.6), 33.4mmHg (21.1 – 79), 32.4mmHg (19.8 – 93.1) on days 
1-4 respectively – see Figure 6.15.  Peristaltic wave velocity was also similar on the 
four different study days being 5.2cm/s (2.6 – 11.3), 5.3cm/s (2.9 – 15.7), 4.8cm/s 
(2.8 – 26.5) and 4.8cm/s (3.1 – 17.9) on days 1-4 respectively – see Figure 6.16. 
 
6.9.2.d. Intragastric pressure 
Intragastric pressure fell following the meal on each study day.  Comparing 
the median fasting and median postprandial value for each individual showed that 
there was no difference in the change in intragastric pressure following the meal 
between the 4 study days when measured in either inspiration or expiration. The 
median difference being -1.78mmHg (-9.46 – 5.6), -1.4mmHg, (-6.1 – 3.5), -
0.1mmHg, (-5.4 – 5.7) and -0.42mmHg, (-9.2 – 7.7; p>0.032) in inspiration and -
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1.57mmHg (-7.2 – 4.81), -1.83mmHg (-5.21 – 2.05), -0.49mmHg (-5.45 – 4.54) and -
1.5mmHg (-9.19 – 6.15; p>0.112)) in expiration with solutions 1-4 respectively.   
 
6.9.3. Effect of alteration in salivary nitrite on blood pressure and pulse 
There was a significant difference in the change in systolic blood pressure 
(pre to post infusion) between the 4 study days (p= 0.007, by Friedman’s test). 
However, on post-hoc analysis, only the solution containing 0.286mmol/l nitrite 
showed a significant change in systolic blood pressure compared with the control 
solution. The change in systolic blood pressure was -4 mmHg (-29 – 18), 2.5 mmHg 
(-17 - 30; p<0.05 vs. control), -1 mmHg (-15 -24; p=0.85 vs. control) and -12 (-25 6; 
p= 0.17 vs. control) for solutions 1-4 respectively – see Figure 6.17. 
Diastolic blood pressure and pulse rate were similar following infusions on 
each of the four study days – see Figures 6.18 and 6.19. 
 
6.10. Discussion 
The above studies demonstrate that the range of nitrite likely to be present in 
human saliva does not modify gastro-oesophageal function or predispose to gastro-
oesophageal reflux. 
 There are several reasons why we believe our findings are robust and that it 
is very unlikely that a clinically relevant effect has been missed.  Firstly, we studied 
the effect of nitrite over a 100-fold range in saliva nitrite concentrations which 
extended from 50% of the normal lowest fasting concentrations to approximately ten 
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times the peak concentrations reported following human nitrate ingestion.  Secondly, 
we confirmed with strong significance all the previously reported changes in gastro-
oesophageal function following a meal indicating that our study protocol was 
sensitive and robust (32,33). These changes included a fall in LOS pressure, loss of 
distal component of LOS, increase in frequency of TLOSRs and increased 
oesophageal acid exposure.  
On the control day we observed that the fall in LOS pressure following the 
meal was similar during inspiration and expiration when expressed as absolute 
values but greater during expiration when expressed as percentage fall.  The LES 
comprises two main components, the first being the intrinsic sphincter within the wall 
of the distal oesophagus and proximal stomach and the second being the extrinsic 
sphincter formed by the crura of the diaphragm.  The rise in LOS pressure on 
inspiration is due to the increase in pressure exerted by the diaphragmatic crura.  
The intrinsic sphincter makes a greater contribution to the total pressure during 
expiration than inspiration.  The overall LOS pressure is thought to represent the 
sum of the crural pressure plus intrinsic sphincter pressure (34).  The fact that the fall 
in LOS pressure after the meal was proportionally greater during expiration suggests 
that it is due to a fall in the pressure exerted by the intrinsic sphincter.  This may be 
explained by the effects of cholecystokinin released after a fatty meal (159;160). 
We also observed a shortening of the length of the LOS following the meal 
during expiration mainly affecting the abdominal segment.  This is again consistent 
with relaxation of the intrinsic component. 
The ability to detect a change in the intrinsic component of the LOS in our 
study protocol was important as an effect of nitric oxide derived from the luminal 
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nitrite would be on the intrinsic and not extrinsic sphincter.  Previous investigators 
have also demonstrated the ability to detect changes limited to the intrinsic sphincter 
while measuring overall LOS pressure. For example, atropine relaxes the intrinsic 
sphincter but does not affect the diaphragmatic crura and a fall in lower oesophageal 
sphincter pressure can be readily demonstrated following atropine during expiration 
(161). 
Could an effect of nitrite be limited to subjects with erosive oesophagitis 
where the damage to the epithelium might facilitate the nitric oxide reaching the 
intrinsic muscle layer of the oesophagus.  It is probable that such subjects would be 
more sensitive to the presence of luminal nitric oxide than healthy volunteers.  
However, in our study, the luminal nitrite concentration on one study day was 10 
times higher than the upper range of normal and an effect would have been 
expected at this very high level even in subjects with an intact epithelium. 
 Webb et al have previously described a significant reduction in systolic blood 
pressure following dietary nitrate supplementation (162).  In our own study, the only 
significant change in blood pressure or pulse was an increase in systolic blood 
pressure following infusion of the solution containing 0.286mmol/l nitrite. However, 
with increasing dose of nitrite, there was a trend toward decreasing systolic blood 
pressure. In the study by Webb et al, depending on bacterial conversion of the re-
circulated nitrate, the amount of nitrite delivered may have been up to 9 times higher 
than the maximum nitrite load in our study. Also, unlike the study by Webb et al 
where regular blood pressure measurements were recorded using an automated 
machine for up to 24 hours, BP and pulse were only recorded before initial nasal 
intubation of pH manometry apparatus and after completion of the infusion. 
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Therefore, a transient effect of the administered nitrite during infusion could easily 
have been missed. Similarly a delayed effect on BP, as occurs in the study by Webb 
et al, would not have been detected. The possibility we may have missed a transient 
BP effect during the infusion of nitrite is supported by their observations that the in 
vivo half life of nitrite (~1.5 hours) was significantly longer than the ex vivo half life (< 
2 minutes), suggesting that nitrite was being continuously produced from nitrate (half 
life of ~ 8 hours) by entero-salivary recirculation. Without recirculation of dietary 
nitrate, in our own study the in vivo half life of the delivered nitrite is likely to be short. 
In another previous study by our own group, Manning et al examined the 
effect of infusing a nitrous acid solution and a nitric oxide generating infusion into 
gastric cardia. Results were compared with the infusion of a control solution 
containing hydrochloric acid (pH 1.0). They described an increase in the rate of 
TLOSRs and acid exposure with the NO-generating solution versus control. In 
addition, there was an attenuation of the postprandial increase in IGP following 
infusion of the nitrous acid infusion. In our study neither of these changes were 
demonstrated. However, differences in methodology between the two studies may 
be important. In the study by Manning et al infusions were delivered directly into the 
gastric cardia while, in our study, nitrite is continually infused into the oral cavity. In 
our study therefore, nitrite is not delivered to the GOJ until saliva is swallowed and 
therefore delivery of nitrite is intermittent which is analogous to the physiological 
delivery of nitrite in normal saliva. By continuously exposing the distal oesophagus, 
LOS and stomach to nitric oxide or nitrous acid without time to ‘recover’ Manning et 
al may have provoked an increase in TLOSRs which would not be induced by the 
physiological delivery of nitrite. In addition it is possible that following the infusion of 
91 
 
the NO generating infusion into the gastric cardia, the increase in TLOSRs may have 
been triggered by distension of the proximal stomach. This may have occurred due 
to the production of NO gas which would have had a similar effect to the instillation 
of air into the proximal stomach which is recognised as a potent stimulator of 
TLOSRs. Any increase in the rate TLOSRs could explain the increase in acid 
exposure recorded.  Finally as well as infusing nitrous acid and hydrochloric acid into 
the gastric cardia, Manning et al infused ascorbic acid as part of the NO-generating 
solution. As a result, the GOJ was exposed to super-physiological levels of ascorbic 
acid potentially leading to greater than physiological NO production. In our study no 
additional ascorbic acid was given, thus NO production is likely to be more in the 
physiological range and may therefore be reduced when compared with Manning et 
al. 
 
6.11 Conclusion 
Our study demonstrates that salivary nitrite and its associated nitric oxide 
production on reaction with acid at the gastro-oesophageal junction does not 
influence integrity of the gastro-oesophageal barrier in healthy volunteers. 
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Table 6.1. Baseline characteristics of study group 
Parameter Value 
Total Subjects Recruited 25 
Completed Study 20 (80%) 
Sex Male 11 (55%) Female 9 (45%) 
Helicobacter Status Positive 3 (15%) Negative 17 (85%) 
Age (y) 26.5 (range 19 – 59) 
Height (m) 1.72 (range 1.55 – 1.84) 
Weight (kg) 75.0 (range 55 – 110) 
BMI (kg/m2) 23.7 (range 18.6 – 35.5) 
Waist Circumference (cm) 83.5 (range 67 – 110) 
Baseline Systolic BP (mmHg) 125 (range 114 – 161) 
Baseline Diastolic BP (mmHg) 75 (range 61 – 90) 
Baseline Pulse Rate (bpm) 70 (range 48 – 98) 
Values are medians (range) unless otherwise stated 
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Table 6.2. Holloway criteria for definition of transient lower oesophageal sphincter 
relaxations (TLOSRs) (20) 
Criteria 
1. Absence of swallowing for 4s before to 2s after r, the onset of LOS relaxation 
AND 
2. Relaxation rate of ≥1mmHg/s 
AND 
3. Time from onset to complete relaxation of ≤10 seconds 
AND 
4. Nadir pressure ≤2mm 
OR 
5. Any pressure falls fulfilling criteria 2-4 but with duration >10 seconds (excluding 
those associated with multiple swallows) 
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Table 6.3. Changes in gastro-oesophageal function following the meal 
 Fasting Post-prandial p value 
5-6cm Acid Exposure 
(% time pH<4) 
0 (0–1.9) 0.5 (0-20) p = 0.002 
1-2cm Acid Exposure 
(% time pH<4) 
1.2 (0-7.8) 6.0 (0.9-74.4)  p < 0.001 
Rate of TLOSRs 
(number/h) 
0 (0-4) 7.3 (4-11.3) p = 0.001 
Expiratory LOS 
Pressure vATM 
(mmHg) 
29.4 (11.8-51.2) 19.2 (8.2-34.5) p < 0.001 
Expiratory LOS 
Pressure vIGP 
(mmHg) 
17.3 (4.9-37.7) 12 (4-23.8) p < 0.001 
Inspiratory LOS 
Pressure vATM 
(mmHg) 
39.5 (16.9-60.2) 30.4 (14.5-53.1) p = 0.02 
Inspiratory LOS 
Pressure vIGP 
(mmHg) 
25.4 (10.1-43.9) 18.1 (6.5-40.3) p = 0.035 
LOS Length (cm) 5 (3-6) 4 (1-6) p = 0.001 
Inspiratory 
Intragastric Pressure 
(mmHg) 
12 (6-20) 10.2 (4.5-21.8) p = 0.059 
Expiratory 
Intragastric Pressure 
(mmHg) 
10.5 (4.5-19.1) 8.9 (3.2-20.4) p = 0.089 
TLOSRs, transient lower oesophageal sphincter relaxations; LOS, lower oesophageal 
sphincter; vATM, relative to atmospheric pressure; vIGP, relative to intragastric pressure.  
Results are expressed as medians (range). Significant p values (p <0.05) are highlighted in 
bold.
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Table 6.4. Salivary nitrite concentrations and gastro-oesophageal and cardiovascular 
function on the four study days 
 0mmol/l 0.286mmol/l 2mmol/l 14mmol/l p value 
Nitrite Concentration 
(mmol/l)* 
24.4 (3.9–65.5) 80.4 (20.9-158.8) 
358.4 (118.2-
726.6) 
2694 (600-8087) p < 0.001† 
5-6cm Acid Exposure 
(% time pH<4) 
0.4 (0.0 – 20.0) 1.1 (0.0-35.8) 1.0 (0.0-28.1) 0.6 (0.0-31.5) p = 0.214 
1-2cm Acid Exposure 
(% time pH<4) 
6.0 (0.8-74.4) 6.4 (0.8-86.6) 9.7 (0-93.2) 5.7 (0.1-68.6) p = 0.981 
No. of TLOSRs 11.0 (6.0-17.0) 13.0 (6.0-17.0) 12.0 (6.0-17.0) 12.0 (7.0-18.0) p = 0.117 
Change in Expiratory 
LOSP vATM (mmHg) 
– 8.0 (-26.1–2.1) -7.8 (-37.6-7.7) -5.7 (-42.4-12.8) -8.3 (-55.6-4.1) p = 0.776 
Change in Expiratory 
LOSP vIGP (mmHg) 
-7.1 (-22.9-3.2) -4.9 (-37-5.8) -6.8 (-42.1-14.7) -8.5 (-51.8-2.2) p = 0.73 
Change in Inspiratory 
IGP (mmHg) 
-1.8 (-9.5-5.6) -1.4 (-6.1-3.5) -0.1 (-5.4-5.7) -0.4 (-9.2-7.7) p = 0.13 
Change in Expiratory 
IGP (mmHg) 
-1.6 (-7.2-4.8) -1.8 (-5.2-2.1) -0.5 (-5.5-4.5) -0.2 (-9.2-6.6) p = 0.312 
No. of Reflux Events 2.5 (0.0-11.0) 5.0 (0.0-16.0) 4.0 (0.0-17.0) 2.5 (0.0-13.0) p = 0.429 
Nadir pH of Reflux 1.6 (0.6-3.7) 1.5 (0.7-3.3) 1.6 (0.7-3.2) 1.6 (0.8-3.1) p = 0.681 
Duration of Reflux 
(secs) 
12.8 (3.1-264.1) 15 (3.2-301.2) 17.7 (3.1-353.3) 13.3 (3.1-473.4) p = 0.614 
Peristaltic Amplitude 
(mmHg) 
36.6 (18.5-98.7) 33.6 (19.4-83.6) 33.4 (21.1-79.0) 32.4 (19.8-93.1) p = 0.936 
Peristaltic Velocity 
(cm/s) 
5.2 (2.6-11.3) 5.3 (2.9-15.7) 4.8 (2.8-26.5) 4.8 (3.1-17.9) p = 0.093 
Change in SBP (mmHg) -4.0 (-29.0-18.0) 2.5 (-17.0-30.0) -1.0 (-38.0-29.0) -12.0 (-25.0-6.0) p = 0.007‡ 
Change in DBP (mmHg) -1.0 (-18.0-11.0) -4.0 (-27.0-17.0) 1.0 (-15.0-24.0) -3.0 (-27.0-6.0) p = 0.316 
Pulse (bpm) -2.5 (-20.0-14.0) -2.0 (-23.0-6.0) -3.5 (-22.0-18.0) 1.5 (-22.0-6.0) p = 0.903 
 
TLOSRs, transient lower oesophageal sphincter relaxations; LOSP, lower oesophageal sphincter pressure; 
vATM, relative to atmospheric pressure; vIGP, relative to intragastric pressure; SBP, systolic blood pressure; 
DBP, diastolic blood pressure. *Median nitrite concentrations at 60minutes post-prandial. Results are 
expressed as medians (range).  
Significant p values (p <0.05) are highlighted in bold. 
† Post-hoc test: (0.286 vs. 0), (2 vs. 0), and (14 vs. 0), p value for each was <0.001; ‡ Post-hoc test: (0.286 vs. 
0) p value <0.05, (2 vs. 0) p value = 0.850, and (14 vs. 0) p value = 0.170. 
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Figure 6.1. The effect of nitrite in saliva on gastro-oesophageal reflux – study day outline 
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Figure 6.2. Box-plot showing the effect of the meal on oesophageal acid exposure 
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Figure 6.3. Box-plot showing the effect of the meal on the rate of transient lower 
oesophageal relaxations (TLOSRs) 
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Figure 6.4. Line graph illustrating the proportional fall in LOS pressure after the meal 
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Figure 6.5. Box-plot showing the change in lower oesophageal sphincter length after the 
meal 
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Figure 6.6. Box-plot showing the change in intra-thoracic sphincter length after the meal 
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Figure 6.7. Box-plot showing the change in intra-abdominal sphincter length after the 
meal 
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Figure 6.8. Line graph showing the change in intragastric pressure during study – control 
day 
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Figure 6.9. Box-plot of salivary nitrite concentrations between solutions - measured 60 
minutes into study 
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Figure 6.10. Box-plot of post-prandial acid exposure between solutions - measured 5-6cm 
above the fasting pH step-up point 
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Figure 6.11. Box-plot of post-prandial acid exposure between solutions - measured 1-2cm 
above the fasting pH step-up point 
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Figure 6.12. Box-plot showing the duration of individual post-prandial reflux events 
between solutions 
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Figure 6.13. Box-plot showing the nadir pH of individual post-prandial reflux events 
between solutions 
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Figure 6.14. Box-plot showing the number of post-prandial transient lower oesophageal 
sphincter relaxations (TLOSRs) between solutions 
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Figure 6.15. Box-plot showing the post-prandial peristaltic wave amplitude between 
solutions 
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Figure 6.15. Box-plot showing the post-prandial peristaltic wave velocity between 
solutions 
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Figure 6.17. Box-plot showing the change in systolic blood pressure between solutions 
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Figure 6.18. Box-plot showing the change in diastolic blood pressure between solutions 
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Figure 6.19. Box-plot showing the change in pulse rate between solutions
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Chapter 7  
The Effect of Nitrite in Saliva on Gastric Emptying 
 
7.1 Introduction 
Human saliva has a high nitrite concentration derived from the entero-salivary 
recirculation of dietary nitrate. Swallowed nitrite reacts with acidic gastric juice 
forming nitrous acid, nitrosating species and nitric oxide (NO). Increasing NO 
bioactivity, by inhibiting phosphodiesterase, enhances gastric accommodation and 
delays gastric emptying (91). Recently, our group described attenuation of the 
postprandial rise in intragastric pressure (IGP) following intragastric nitrous acid 
infusion (93). We now wish to examine the effect of salivary nitrite on gastric 
emptying. 
 
7.2. Aims 
The aims of this study were: 
i. to investigate whether nitrite in saliva affects gastric emptying 
ii. to determine whether nitrite in saliva alters postprandial IGP 
 
7.3. Subjects 
20 subjects (11 male) with a mean age of 30.8 years (Range 19 – 59) were 
studied. Helicobacter status was determined using rapid urease test with 17 testing 
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negative and 3 positive for Helicobacter pylori infection. All subjects were free of 
symptoms of gastro-oesophageal reflux and were not on any regular anti-secretory 
medications.  
 
7.4. Methods 
Gastric emptying studies following modification of salivary nitrite concentration 
were performed on 4 separate study days – the study day outline is shown in Figure 
7.1. Each patient acted as their own control. Volunteers attended for each study day 
fasted from the night before. To measure changes in intragastric pressure, high-
resolution manometry studies were also performed on each study day. 
 
7.4.1. High-resolution manometry 
High-resolution manometry was performed using the Manoscan® system 
(Sierra Scientific Instruments Inc). At the beginning of each study, the manometry 
apparatus was passed per nasally and attached at the nose using adhesive tape. 
Volunteers were given 15 minutes to get used to the apparatus. Manometry 
recording was then performed for 15 minutes in the fasting state prior to the 
consumption of a standardised meal, and continued for 90 minutes post-prandially. 
 
7.4.2. Gastric emptying test 
Gastric emptying was assessed by means of a specially designed breath test 
which was based on the method described by Meier- Augenstein et al (163). This 
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uses 14C labelled sodium acetate incorporated into a flapjack consisting of butter, 
syrup and rolled oats during the baking process. The flapjack was prepared in 
batches and constituted part of our standardised meal.  
Following consumption of the flapjack, breath samples were taken at regular 
intervals to assess gastric emptying. Samples are taken at baseline then 10 minute 
intervals for 1 hour followed by 15 minute intervals for the subsequent 2 hours. 14CO2 
breath samples were collected in hyoscine hydroxide and ethanol scintillation 
medium. Each sample contains 1mmol of CO2 and is analyzed by beta scintillation 
counting. 
 
7.4.2.a. In vitro validation study of gastric emptying test 
Prior to the study, the radio-labelled flapjack was evaluated as an accurate 
and reproducible marker of the solid phase of a meal by assessing retention of the 
14C labelled sodium acetate in the solid phase under gastric simulation. 2g aliquots 
of the flapjack were added to 10mls of gastric juice (pH 1.44) obtained from a healthy 
volunteer and 1ml of fresh human saliva. Samples were immersed in a water bath at 
37ºC and mixed at regular intervals to simulate gastric motor activity. 4 individual 
samples were analysed at 30, 60, and 180 minutes. Samples were taken from the 
liquid phase to measure release of the tracer. The results were expressed as the 
mean percentage of the initial radioactivity that remained in the solid phase. 
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7.4.3. Standardised meal 
Each volunteer was given a standardised meal, consisting of two haddock 
and potato fishcakes and one rolled oats flapjack with 150ml of water (Total calorie 
content: 526.35 kcal). 20 minutes was allocated for consumption of the meal. 
 
7.4.4. Nitrite infusions 
Infusions of the test solutions into the mouth commenced immediately after 
completion of the meal and continued for 90 minutes post-prandially. 
 
7.5. Analysis 
7.5.1. Gastric emptying 
Total CO2 production was taken to be 300 millimoles per square metre of 
body surface per hour. Body surface area was calculated by the formula previously 
described by Haycock et al (164). The quantity of 14C appearing in breath per unit 
time (µmol/minute) was calculated. The mathematical model described by 
Viramontes et al was used to estimate gastric half-emptying times (T½). This used 
only 4 breath samples at 45, 90, 105 and 120 minutes (165). In this method, the 
gastric emptying T½ is estimated directly as T½ = 1/LP½, where the linear predictor 
(LP½) is given by: 
LP½ = 0.0025 – 0.0039 x 
14C45 + 0.0088 x 
14C90 – 0.0063 x 
14C105 + 0.0024 x 
14C120 
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7.5.2. Intragastric pressure 
Intragastric pressure was defined, relative to atmospheric pressure, as the 
median pressure in the 3 sensors immediately distal to the LOS. 
 
7.6. Statistical analysis 
All results are given as medians and interquartile ranges unless otherwise 
stated. To test the changes of variables against different nitrite solutions, the 
nonparametric Friedman’s test was used. 
 
7.7. Ethics 
The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant. 
 
7.8. Results 
7.8.1. In vitro validation study of gastric emptying test 
The bench top study confirmed the retention of the majority of tracer in the 
solid phase of the meal under gastric simulation. At 30, 60 and 180 minutes the 
mean percentage 14C retention in the solid phase was 83.9% (range 73.7 – 89.6%), 
74.6% (range 65.3 – 79.2%) and 62.44% (range 52.1 – 66.4%) respectively - see 
Table 7.1. 
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7.8.2 Salivary nitrite concentrations 
There was a significant difference in the median salivary nitrite concentrations 
during infusion of each solution. At 60 minutes following the meal the median 
concentrations of salivary nitrite recorded were 24.35µmol/l (range 3.86 – 65.46), 
80.42µmol/l (range 20.88 – 158.79; p<0.001 v control), 372.86µmol/l (range 118.2 – 
726.6; p<0.001 v control) and 2398.53µmol/l (range 600 – 8087; p< 0.001 v control) 
for the solutions containing 0mmol/l, 0.286mmol/l, 2mmol/l and 14mmol/l potassium 
nitrite respectively. The salivary nitrite concentration results are shown in Table 7.2. 
To save space in presenting results, the four different study days will be 
referred to as 1, 2, 3, 4 with one being the lowest nitrite concentration (control) and 4 
the highest. 
 
7.8.3. Gastric emptying – control v nitrite solutions 
There was no significant difference in the rate of gastric emptying of the test 
meal between the different study days with the T½  being 39.79 minutes, (range 
10.94 – 136.69), 32.25 minutes, (range 15.69 – 108.36); 33.98 minutes, (range 
24.91 – 121.96) and 37 minutes, (range 19.7 – 363) for solutions 1 - 4 respectively. 
Results are shown in Figure 7.2. 
 
7.8.4. Intragastric pressure – control v nitrite solutions 
Intragastric pressure fell following the meal on each study day.  Comparing 
the median fasting and median postprandial value for each individual showed that 
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there was no difference in the change in intragastric pressure following the meal 
between the 4 study days when measured in either inspiration or expiration. Results 
are shown in Figures 7.3. and 7.4. 
 
7.9. Discussion 
Our initial in vitro results support the previous observation by Meier- 
Augenstein et al that the sodium acetate-labelled ‘radioactive flapjack test’ is a 
reliable measure of solid-phase gastric emptying (163). The sodium acetate breath 
test had previously been described as an accurate, reliable and non-invasive tool for 
the analysis of liquid phase gastric emptying rates (166). Meier-Augenstein’s work 
subsequently demonstrated retention of a majority of the tracer in the solid phase of 
the meal if incorporated in the baking process of a rolled-oats flapjack. Similar results 
were found in our own study with a majority of the tracer retained in the solid phase 
under simulated intragastric conditions out to 180 minutes. Confirmation of tracer 
retention in the solid phase was important as measurement of solid gastric emptying 
is recognised to be more sensitive than measurements of liquid gastric emptying in 
detecting individuals with delayed gastric emptying (167)  
We calculated the gastric half-emptying time (T½) as a measure of the rate of 
gastric emptying.  Initially we used the mathematical model previously described by 
Ghoos et al (168;168), by fitting the percentage14C recovery per minute by non-linear 
regression to the formula y = abte-ct and the cumulative recovery of 14C to the formula 
y = m(1-e-kt)β, the inverse of the scintigraphic decay curve. Through mathematical 
114 
 
curve fitting, it is then possible to calculate the gastric half-emptying time (T½) using 
the equation (-1/k)ln(1-2-1/β). 
However, using the Ghoos method, we frequently observed an atypical 
double-peak in our excretion curves. This has previously been described by Sanaka 
et al and inevitably results in poor curve-fitting. Such a phenomenon was seen in at 
least one gastric emptying study in 14/20 subjects (70%). One possible cause for the 
frequency of this ‘double-peak’ phenomenon in our own study may have been that 
the nitrite infusion and manometry studies were only continued for 90 minutes, not 
the full 180 minutes over which breath testing was performed. Even in the absence 
of a direct effect of salivary nitrite on gastric emptying these changes, including 
removal of the nasogastric manometry catheter may have an impact upon gastric 
emptying. As a result of this finding, the mathematical model described by 
Viramontes et al, and detailed in the methods section above, was preferred for 
estimation of gastric half-emptying times (T½). 
Despite an excellent range of modified salivary nitrite concentrations 
extending over and beyond the normal physiological range, we were unable to 
demonstrate any effect of salivary nitrite modification on gastric emptying or 
postprandial changes in IGP. 
In previous work by Manning et al from our own group, the effect of infusing a 
nitrous acid solution and a nitric oxide generating infusion into gastric cardia was 
studied. The researchers found that there was an attenuation of the postprandial 
increase in IGP following infusion of the nitrous acid infusion. It was therefore 
postulated that this may have been due to a delay in gastric emptying. In our study 
neither an attenuation in IGP nor a delay in gastric emptying was observed. 
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However, as detailed in the previous chapter, differences in methodology between 
the two studies may be important. In particular the mode of delivery of infusions and 
the excess ascorbic acid delivered to the GOJ and stomach may produce results 
which would not be seen with the more physiological delivery of nitrite we have 
employed. 
While our in vitro gastric simulation confirms that the majority of tracer is 
retained in the solid phase of the meal throughout our study, the actual amount of 
tracer retained in the solid phase is lower than either Meier-Augenstein (74.6% v 
95.2% at 1 hour) or Ghoos (62.4% v 86.8% at 3 hours) have described (163;168). 
Similarly, the median gastric half-emptying times we obtained are significantly 
shorter than those obtained by Ghoos et al in their study using a 14C-octanoic acid 
solid emptying breath test meal correlated with radioscintigraphy. Indeed our results 
more closely resemble their median values for the lag phase of solid gastric 
emptying. No lag phase is present in liquid emptying and the lower in vitro retention 
and shorter emptying times may suggest that we have in fact measured liquid rather 
than solid gastric emptying. Although solid emptying may be more sensitive in 
detecting delayed gastric emptying, the majority of patients with gastric emptying 
disorders have delayed emptying of both liquids and solid food. The use of subjects 
as their own control makes it unlikely any significant effect of salivary nitrite on 
gastric emptying would have been missed.  
It is also possible that liquid gastric emptying is more relevant to GORD than 
solid emptying. The rate of liquid emptying is largely determined by the degree of 
fundic relaxation (accommodation) while the emptying of solids depends more on 
antral motility (169). Abnormalities in gastric accommodation are more likely to lead 
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to increased pressure in the proximal stomach and, through the generation of 
TLOSRs, to increased gastro-oesophageal reflux. Importantly, in the study by 
Sarnelli et al where they examined the impact of increasing NO bioavailability by 
using the phosphodiesterase inhibitor Sildenafil, they demonstrated an increased in 
gastric accommodation and a delay in liquid rather than solid gastric emptying (91). 
 
7.10 Conclusion 
Despite an excellent range of salivary nitrite concentrations, extending over 
and beyond the normal physiological range, no difference in the rate of gastric 
emptying or postprandial rise in IGP was seen. This suggests salivary nitrite does 
not affect gastric emptying. 
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Table 7.1. In vitro study of tracer retention in the solid phase 
Time (Minutes) 14C Retention (%) 
30 83.9 (73.7 – 89.6) 
60 74.56 (65.3 – 79.2) 
180 62.44 (52.1 – 66.4) 
Values are medians (range) 
 
Table 7.2. Salivary nitrite concentrations (mmol/l) at baseline and during 90 minute post-
prandial infusion 
Time 
0mmol/l 
Solution 
0.286mmol/l 
Solution 
2mmol/l 
Solution 
14mmol/l 
Solution 
0 minutes 18.77 22.73 19.01 25.25 
30 minutes 28.61 60.95 349.68 2776.28 
60 minutes 24.35 80.42 358.44 2693.83 
90 minutes 26.49 32.84 138.56 886.45 
Results shown are median values. 
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Figure 7.1. The effect of nitrite in saliva on gastric emptying – study day outline 
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Figure 7.2. Box-plot showing gastric half-emptying time between solutions 
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Figure 7.3. Box-plot showing the change in intragastric pressure (inspiratory) between 
solutions 
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Figure 7.4. Box-plot showing the change in intragastric pressure (expiratory) between 
solutions 
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Chapter 8 
Detailed Analysis of Post-prandial Changes in Gastro-oesophageal 
Morphology and the Effect of Salivary Nitrite 
 
8.1. Introduction 
30-50% of upper gastrointestinal tract adenocarcinomas occur at the gastro-
oesophageal junction (GOJ) or gastric cardia. Unlike oesophageal adenocarcinoma, 
the association with reflux is weak. In studies using pull through pH and manometry, 
we have observed loss of the distal segment of the lower oesophageal sphincter 
(LOS) with the pH step-up point moving closer to or even across the 
squamocolumnar junction (SCJ). This distal opening may explain the high incidence 
of pathology at the GOJ in asymptomatic subjects. 
 
8.2. Aims 
The aims of this study were to investigate, in healthy subjects using static high 
resolution manometry 
i. the effect of a meal on manometric changes in the gastro-oesophageal 
high pressure zone (HPZ), the location of the pH step-up point and the 
position of the SCJ  
ii. whether nitrite in saliva influences the effect of a meal on manometric 
changes in the gastro-oesophageal high pressure zone (HPZ), the 
location of the pH step-up point and the position of the SCJ 
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8.3. Subjects 
20 healthy subjects (11 males, 17 Helicobacter Pylori negative) were studied 
over 4 separate study days. 
 
8.4 Methods 
8.4.1. Endoscopic placement of radio-opaque clip at the squamocolumnar 
junction (SCJ) 
A minimum of 24 hours prior to the first study day, subjects attended for upper 
gastrointestinal endoscopy. At endoscopy, a radio-opaque 11mm stainless steel 
endoclip (Olympus HX-600-090) was placed at the macroscopic squamo-columnar 
junction using an endoscopic clip-fixing device (Olympus HX-5LR-1). Placement of 
this clip allowed subsequent fluoroscopic localisation of the SCJ. 
 
8.4.2. pH manometry 
On each study day, combined high-resolution pH manometry apparatus was 
passed per nasally as previously described. The apparatus was secured at the nose 
using adhesive tape and 15 minutes allowed for subject accommodation to the 
apparatus. Following this, synchronized recording of pH and manometry was 
performed for 15 minutes fasting, during our standardized meal and for 90 minutes 
post-prandially. 
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8.4.3. Standardized meal 
Our standardized meal consisted of two fishcakes and one rolled oats flapjack 
with 150ml water.  (Total caloric content = 526.35kcal).   
 
8.4.4. Nitrite infusions 
Infusions of the test solutions into the mouth commenced immediately after 
completion of the meal and continued for 90 minutes post-prandially. 
 
8.4.5. X-ray localization of the SCJ 
X-ray screening of the gastro-oesophageal junction was carried out during 
normal respiration using a portable C-arm fluoroscope (Philips BV Pulsera). 
Screening was performed both in the fasting state and following the meal for 
approximately 30 seconds and synchronized with pH manometry recordings using a 
radio-opaque event marker. Images were recorded using a digital video recorder 
(JVC SR-DVM600E). 
 
8.5. Analysis 
8.5.1. Detailed Analysis of the Gastro-oesophageal Junction 
To examine the gastro-oesophageal junction in more detail, 10 second 
periods of stable sphincter tone out with sphincter relaxations were identified using 
the Manoview Analysis software during fasting and for each of the 6 consecutive 15 
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minute periods following completion of the meal. The raw data was extracted and 
analysed to determine the mean positions of the distal border of the lower 
oesophageal high pressure zone (DHPZ), the proximal border of the lower 
oesophageal high pressure zone (PHPZ), the respiratory inversion point (RIP) and 
the pH step-up point. The DHPZ was defined as the most distal point where there 
was an increase of >2mmHg in pressure above the sensor recording gastric baseline 
pressure (defined as the lowest mean pressure in the most distal 6 manometry 
sensors). The PHPZ was identified as the point where there was a step-down in 
pressure to intra-oesophageal pressure. The RIP was defined as the point at which 
the manometry pressure wave decreases on inspiration. The pH step-up point was 
identified as the point where the mean pH increased to >4. The mean length of the 
high pressure zone (HPZ), the intra-abdominal component of the HPZ and the intra-
oesophageal component of the HPZ were calculated. 
To correct for errors in measuring the position of the PHPZ, DHPZ and RIP 
using 1cm increments, 0.5cm was added to the distance from the nares for each 
measurement. Similarly to correct for errors in measurement of the pH step-up point 
using 1.1cm increments, 0.55cm was added to the mean position of the pH step-up 
point. 
 
8.5.2. Measurement of SCJ position 
10 second periods of stable sphincter tone, out with sphincter relaxations, 
were identified during screening episodes using the Manoview analysis software. 
Corresponding still X-ray images at 2 second intervals were analysed using image 
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analysis software (Scion Image, Scion Corporation, Frederick, Maryland, USA). The 
position of the clip relative to the pH and manometry catheters was calculated with 
the measured distance of one pH sensor (known to be 1cm) used as an internal 
scale. The mean SCJ position for the 10 second period was calculated. 
 
8.6. Statistical Analysis 
Statistical analysis was performed using the one-sample Wilcoxon test or 
Mann Whitney U unless specified otherwise. The Bonferroni method was used to 
correct for the use of multiple comparisons with value of p<0.0083 considered 
significant.  
 
8.7. Ethics 
The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant 
 
8.8. Results 
8.8.1. Salivary Nitrite Concentrations 
There was a significant difference in the median salivary nitrite concentrations 
during infusion of each solution. 
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8.8.2. Changes after the meal – control solution 
8.8.2.a. Detailed analysis of the gastro-oesophageal junction 
Following the meal the PHPZ was unchanged from its fasting state but there 
was significant shortening of the HPZ, a maximum of 2.08cm (-0.48 – 5.59; p<0.001) 
see Figure 8.1. There was, therefore, significant proximal movement of the DHPZ 
relative to the nares, a maximum of 2.14cm (-1.37 – 4.23; p<0.001). In addition there 
was proximal movement of the RIP relative to the PHPZ, a maximum 1.09cm (0 - 
1.43; p<0.001), as a result there was shortening of both the intra-oesophageal 
(maximum 1.11cm, range -0.55 – 4.36; p<0.001) and intra-abdominal (maximum 
1.15cm, range -1.43 – 3.53; p=0.007) components of the HPZ. The pH step-up point 
also moved proximally, a maximum of 1.61cm (-1.49 – 5.15; p<0.001). The changes 
occurring at the GOJ following the meal are illustrated in Figure 8.2. 
 
8.8.2.b. SCJ position 
18 subjects underwent X-ray screening on the day of the control infusion. In 
the remaining 2 subjects, videofluoroscopy equipment was unavailable at the time of 
study. In 5 of the subjects screened the endoclip had spontaneously dislodged and 
they were excluded from further analysis. SCJ position was calculated in the 
remaining 13 subjects. Following the meal the DHPZ moved significantly closer to 
the SCJ, a median 1.72cm (-0.37-2.93, p=0.004). However, there was no difference 
in the position of the pH step-up point relative to the SCJ between the fasting and 
postprandial screening episodes with the median position being 0.62cm distal to SCJ 
(-2.25–5.93, p>0.4). These results are illustrated in Figure 8.3. 
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An illustration of the changes at the GOJ following the meal is shown in Figure 8.4. 
8.8.3. Effect of Salivary Nitrite on GOJ Morphology 
8.8.3.a. Detailed Analysis of the Gastro-oesophageal Junction 
The position of the PHPZ following the meal was similar between all the 
solutions (p>0.08). There was no difference in the position of the RIP following the 
meal between the control solution and the nitrite-containing solutions (p>0.05). With 
all solutions, the median length of the HPZ and the length of both the intra-
oesophageal HPZ and the intra-abdominal HPZ was reduced following the meal with 
no significant difference in lengths between the control solution and the nitrite-
containing solutions (p>0.05, p>0.01 and p>0.13) respectively. Finally, the median 
distance of the pH step-up point relative to the PHPZ was reduced following the meal 
with all solutions, again there was no difference in the position of the pH step-up 
point relative to the PHPZ between the control solution or the nitrite-containing 
solutions (p>0.04). These results are shown in Figures 8.5. – 8.7. 
 
8.8.3.b. SCJ position 
Due to lack of availability of equipment or spontaneous clip dislodgement, 
only 7 subjects had suitable X-ray screening images available for comparison 
between all solutions. There was no significant change in the position of the pH step 
up point relative to the SCJ following the meal between the control solution (0.69cm, 
-0.26-2.97) and those containing 0.286mmol/l (-0.69cm, -5.15 – 0.15; p>0.03 v 
control), 2mmol/l (-0.24cm, -2.08 – 2.86; p>0.1 v control) and 14mmol/l potassium 
nitrite (-1.07cm, -2.39 - 4.9; p>0.15 v control). With all solutions, following the meal 
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the DHPZ moved closer to the SCJ but there was no difference between the control 
solution (-0.26cm, -2.7 - 0.37) and those containing 0.286mmol/l (-0.8cm, -3.21 – 
0.5; p>0.93 v control), 2mmol/l (-0.89cm, -3.42 – 0.51; p>0.35 v control) and 
14mmol/l potassium nitrite (-0.38cm, -3.64 – 1.15; p>0.67 v control) when the 
change in DHPZ position relative to the SCJ was compared. 
 
8.9. Discussion 
This study combines, for the first time, high resolution pH manometry with X-
ray localization of the SCJ to provide detailed analysis of the GOJ during fasting and 
in the post-prandial state. By analysing the GOJ in more detail, we have 
demonstrated that following the meal there is no difference in the position of the 
PHPZ but significant proximal movement of the DHPZ. As a result there is significant 
shortening of the HPZ. Proximal movement of the RIP occurs which would be 
consistent with cephalic displacement of the diaphragm by a distended stomach. 
With X-ray screening the DHPZ is seen to move significantly closer to the SCJ after 
the meal and the pH step up point migrates proximally. These changes are 
consistent with distal opening of the LOS. This mechanism was first proposed by 
Oberg and DeMeester (94;106) and has recently been demonstrated using pull-
through manometry (93;170). It has been proposed as a mechanism by which distal 
oesophageal exposure may occur (intra-sphincteric reflux) and as a possible 
explanation for the recently described paradox of postprandial acidification of the 
gastric cardia (171). This is the first study using static high-resolution manometry 
which confirms distal opening of the LOS after meals. The fact that we were unable 
to demonstrate any change in the position of the pH step-up point relative to the SCJ 
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after the meal, consistent  with intra-sphincteric reflux, is likely to be due to the 
methods used in our study and the subjects examined. Studies were performed with 
subjects semi-recumbent at 45º to the horizontal, while the screening group also had 
a median body mass index (BMI) in the normal, healthy range of 23.92. Intra-
sphincteric reflux is presumably more likely to occur in obese subjects in whom 
cephalic displacement of the diaphragm and raised intragastric pressures are well 
documented (121;146-148). Similarly posture is likely to be important with cephalic 
displacement of the diaphragm being well documented to occur on lying flat. (149). 
 
8.10. Conclusion 
  This study confirms, using high-resolution pH manometry, that distal opening 
of the LOS and proximal migration of the pH step-up point occurs after a meal. The 
results suggest that this may in part be mediated by proximal movement of the 
diaphragm. This mechanism may be important in the pathogenesis of disease at the 
GOJ. However, no effect on post-prandial gastro-oesophageal morphology was seen 
with modification of salivary nitrite concentrations.  
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Figure 8.1. Line graph showing significant shortening of the LOS postprandially 
*maximum 2.08cm (range -0.48-5.59cm) at 60-75 mins (p<0.001) 
 
 
 
 
 
Figure 8.2. Line graph showing changes occurring at the GOJ following the meal 
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Figure 8.3. Line graph showing the change in the position of the SCJ and pH step-up point 
post-prandially 
 
Figure 8.4. Illustration of changes occurring at the GOJ following a meal. Results are 
median values at 90 minutes post-prandially. (Note: the median pH step-up point was 
0.2cm proximal to the median SCJ position but this did not reach statistical significance) 
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Figure 8.5. Line graph showing shortening of HPZ following the meal 
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Figure 8.6. Line graph showing pH step-up point moves proximally after the meal 
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Figure 8.7. Box-plot showing the post-prandial position of the pH step-up point relative 
to the SCJ
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Chapter 9 
Increasing Age and Obesity is Associated with Proximal Migration of the SCJ 
in Healthy Volunteers 
 
9.1. Introduction 
The gastric cardia is an important site of pathology with a high incidence of 
inflammation, metaplasia and neoplasia. However this complex area is poorly 
understood and it has been proposed that cardia mucosa itself may be pathological, 
arising from columnar metaplasia of the distal oesophageal squamous mucosa. 
Previous autopsy studies show a near absence of cardia epithelium in neonates and 
an increase in length with age (98;99). 
 
9.2. Aims 
The aims of this study were: 
i. to determine if the position of the squamocolumnar junction (SCJ) 
within the gastro-oesophageal high pressure zone changes with age in 
healthy subjects  
ii. to examine the influence of waist circumference (WC) and body mass 
index (BMI) on squamocolumnar position within the gastro-
oesophageal high pressure zone. 
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9.3 Subjects 
15 Helicobacter pylori negative subjects (9 males) who were free of any 
gastrointestinal symptoms were studied. 
 
9.4. Methods 
Each subject underwent upper GI endoscopy with clipping of a radio-opaque 
endoclip at the squamocolumnar junction. On a separate study day, synchronized 36 
sensor high resolution manometry and videofluoroscopy was performed with 
subjects fasted and in a semi-recumbent position. Age, WC (cm) and BMI (m/kg2) 
were recorded for each individual 
 
9.5. Analysis 
A 10 second analysis period of stable sphincter tone (excluding sphincter 
relaxations) was selected. The proximal high pressure zone (PHPZ) was identified 
from manometry data as a step-down in pressure to the intrathoracic pressure. The 
location of the SCJ was determined using image analysis software (Scion Image, 
Scion Corporation, Frederick, Maryland, USA) with the measured distance of a pH 
sensor (known to be 1cm) used as a scale. The distance between the position of the 
SCJ and the proximal HPZ was calculated for each individual. 
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9.6. Statistical Analysis 
 Spearman’s rank correlation coefficient was used for analysis of non-
parametric data. Results are medians and ranges unless otherwise stated. 
 
9.7. Ethics 
 The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant. 
 
9.8. Results 
 The median age of the subjects was 25 years (20-59 years). The median BMI 
was 22.7 kg/m2 (18.6 - 34.7 kgm2) while the median waist circumference was 82cm 
(66 - 110cm). The median distance between the SCJ and PHPZ was 3.59cm (0.31 - 
4.46cm). The baseline characteristics of our study population are shown in Table 
9.1. 
 
9.8.1. Effect of age on SCJ position 
 There was a strong negative correlation between age and distance between 
SCJ and PHPZ (R = -0.624; p = 0.013) – results shown in Figure 9.1. This 
correlation was even stronger when the male sub-group was analysed (R = -0.814; p 
= 0.008) – results shown in Figure 9.2. 
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9.8.2. Effect of BMI on SCJ position 
 There was a strong negative correlation between age and distance between 
SCJ and PHPZ (R = -0.596; p = 0.019) – results shown in Figure 9.3. This 
correlation was even stronger when the male sub-group was analysed (R = -0.750; p 
= 0.02) – results shown in Figure 9.4. 
 
9.8.3. Effect of waist circumference on SCJ position 
 There was a strong negative correlation between age and distance between 
SCJ and PHPZ (R = -0.525; p = 0.044) – results shown in Figure 9.5. This 
correlation was even stronger when the male sub-group was analysed (R = -0.767; p 
= 0.016) – results shown in Figure 9.6. 
 
9.8.4. Multiple regression analysis 
In multiple regression analysis the combination of both increasing age and 
body mass index was significantly associated with movement of the SCJ closer to 
the proximal HPZ (R2=73.6%, P<0.001) with a strong trend towards significance for 
both individual variables (p=0.053 and p=0.088 respectively). 
 
9.9. Discussion 
Our results indicate that the position of the squamocolumnar junction relative 
to the proximal high pressure zone in Helicobacter Pylori negative individuals is 
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strongly correlated to age. Furthermore the association is stronger in males and 
similar associations can be seen with increasing BMI and waist circumference. This 
is a cross-sectional study and while it confirms that increasing age and obesity are 
associated with proximal migration of the SCJ it cannot determine cause and effect. 
Nevertheless, these findings would be in keeping with previous autopsy studies 
which suggest cardia mucosa may be acquired over time and could be due to 
columnar metaplasia of the most distal oesophageal squamous mucosa.  
If this effect is independent of age-related gastric atrophy, it would support the 
hypothesis that this is due to acid-induced metaplasia. It would suggest that obesity 
and more specifically the central (visceral) obesity seen in males, which correlates 
with waist circumference, may potentiate acidification of the most distal squamous 
oesophageal mucosa. This could be explained either by traditional gastro-
oesophageal reflux or by ‘intra-sphincteric reflux’ where the pH step-up point 
migrates across the SCJ due to distal opening of the LOS following meals. 
 
9.10. Conclusion 
The position of the squamocolumnar junction relative to the proximal high 
pressure zone correlates strongly with age, BMI and waist circumference in healthy 
subjects. This supports proximal migration of the squamocolumnar junction due to 
columnar metaplasia of the distal oesophageal squamous mucosa. 
141 
 
Table 9.1. Baseline characteristics of study participants 
Parameter Value 
Number of Subjects 15 
Sex 
Male 
9 (60%) 
Female 
6 (40%) 
Age (y) 25 (20 – 59) 
Age Range 
<30 y 
9 (60%) 
>30y 
6 (40%) 
Weight (kg) 75.0 (55 – 110) 
BMI (kg/m2) 22.7 (18.6 – 34.7) 
BMI Range 
Normal (<25) 
11 (68.8%) 
Overweight (25-30) 
2 (12.5%) 
Obese (>30) 
3 (18.8%) 
Waist Circumference (cm) 82 (66 – 110) 
Distance from SCJ to PHPZ (cm) 3.59 (0.31 – 4.46) 
Values are medians (ranges) unless stated 
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Figure 9.1. Fitted line plot of age versus distance between SCJ and PHPZ 
 
Figure 9.2. Fitted line plot of age versus distance between SCJ and PHPZ – males versus 
females 
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Figure 9.3. Fitted line plot of body mass index versus distance between SCJ and PHPZ 
 
Figure 9.4. Fitted line plot of body mass index versus distance between SCJ and PHPZ – 
males versus females 
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Figure 9.5. Fitted line plot of waist circumference versus distance between SCJ and PHPZ 
 
Figure 9.6. Fitted line plot of waist circumference versus distance between SCJ and PHPZ – 
males versus females 
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Chapter 10 
A Localised Decrease in Parietal Cell Density Occurs at the SCJ with 
Increasing Age in Asymptomatic Healthy Volunteers 
 
10.1. Introduction 
It has been hypothesized that gastric cardia mucosa may be pathological and 
represent acid-induced columnar metaplasia of the most distal oesophageal mucosa. 
We have shown that the squamocolumnar junction moves closer to the proximal 
border of the lower oesophageal high pressure zone with increasing age. This 
suggests proximal migration of the SCJ with progressive enlargement of the gastric 
cardia may occur over time. This would be expected to be accompanied by a 
reduction in parietal cell density at the SCJ but how much of this is due to age-
related gastric atrophy and is it associated with distal oesophageal acid exposure? 
 
10.2. Aims 
Our aims in this study were: 
i. to investigate whether parietal cell density in the columnar mucosa at 
the squamocolumnar junction (SCJ) changes with age 
ii. to determine whether this is a localised phenomenon or associated 
with more generalised gastric atrophy 
iii. to examine the role of Helicobacter pylori infection 
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iv. to investigate the association of SCJ parietal cell density with distal 
oesophageal acid exposure 
 
10.3. Subjects 
25 healthy volunteers (14 males, 5 Helicobacter pylori positive) were studied.  
 
10.4 Methods 
During upper GI endoscopy, biopsy samples were taken from the 
macroscopic SCJ, 1cm distal to the SCJ, the gastric body and the gastric antrum. 
Biopsies were embedded in paraffin blocks and 5 micron thick sections cut for 
immunohistochemistry. Parietal cells were stained and visualised using a 
standardised monoclonal anti-H+K+ATPase antibody as shown in Figure 10.1. All 
slides were scanned via a digital scanner (Olympus, UK) and uploaded onto a slide 
server. A tissue image analysis programme (SlidePath, Dublin, Ireland) was used to 
quantify parietal cell density in each cell which was reflected as intracellular positive 
pixels. To allow correlation with acid exposure, pH studies were performed in 20 
subjects before and for 90 minutes after our standardised meal of two fishcakes and 
one rolled oats flapjack with 150ml water (Total calorie content = 526.35kcal).   
 
10.5. Analysis 
The average parietal cell density in a minimum of 4 sections of columnar 
mucosa per slide was reported as a percentage of the total cells per section. Acid 
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exposure was calculated 5 - 6cm above the level of the fasting pH step-up point and 
calculated as % time pH<4.  
 
10.6. Statistical analysis 
Spearman’s rank correlation coefficient and the Mann-Whitney U test were 
used for analysis of non-parametric data. Results are medians and ranges unless 
otherwise stated. 
 
10.7. Ethics 
 The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant. 
 
10.8. Results 
10.8.1. Parietal cell density 
 Median parietal cell density results are shown in Table 10.2. 
 
10.8.2. Age and parietal cell density 
There was a significant negative correlation between increasing age and 
parietal cell density in the columnar mucosa at the level of the SCJ (R = -0.530, p = 
0.008). There was no significant correlation between age and parietal cell density 
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1cm distal to the SCJ (R = 0.153, p=0.5), in the gastric body (R = 0.386, p = 0.08) or 
antrum (R = 0.117, p = 0.6). These results are displayed in Figure 10.2. 
In the Helicobacter pylori negative subgroup, parietal cell density at the SCJ 
of volunteers under 30 years old was significantly greater than those aged 30 years 
and over (6.8% (range 0 – 16.3%) v 0.4% (range 0 – 6.3%); p = 0.05). In contrast, 
gastric body parietal cell density was lower in the younger group (30.0% (range 19.9 
– 35.7%) v 34.5% (range 30.5 – 42.7%); p = 0.019. These results are shown in 
Figure 10.3. 
 
10.8.3. Distal oesophageal acid exposure and parietal cell density 
The median % time post-prandial oesophageal pH < 4 was 0.49% (0 - 19.96). 
There was no significant correlation between post-prandial distal oesophageal acid 
exposure and parietal cell density (R = 0.223, p = 0.3) – see Figure 10.4. 
 
10.9. Discussion 
Parietal cell density decreases with age in the columnar mucosa at the SCJ. 
This effect appears to be localised to the SCJ and is not seen 1cm distal to this or 
within the stomach suggesting it is not due to generalized age-related parietal cell 
atrophy. Furthermore, when the Helicobacter negative subgroup was analysed 
separately, while SCJ parietal cell density significantly decreased in the group over 
30 years of age, gastric body parietal cell density actually increased. There was no 
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correlation between parietal cell density and conventional acid reflux, measured as 
%time pH <4 at 5 - 6cm above the fasting pH step-up.  
These results suggest a progressive, localised decrease in parietal cell 
density at the GOJ with increasing age which is due to a mechanism other than 
traditional ‘trans-sphincteric’ gastro-oesophageal reflux. While parietal cell atrophy 
due to Helicobacter pylori infection could explain a reduction in parietal cell density, 
this would be expected to cause more generalized parietal cell atrophy affecting the 
gastric body. In addition, only 5 (20%) of our subjects were Helicobacter Pylori 
positive and sub-group analysis confirmed a reduction in SCJ parietal cell density 
with increasing age in the Helicobacter Pylori negative group. These findings 
therefore support the hypothesis that the gastric cardia is an acquired structure due 
to acid-induced columnar metaplasia. This may occur due to ‘intra-sphincteric reflux’ 
with the pH step-up point migrating across the SCJ due to distal opening of the LOS 
as we, and others in our group, have already described. 
 
10.10. Conclusion 
Parietal cell density decreases with age in the columnar mucosa at the SCJ, 
an effect localised to the GOJ and independent of, conventionally measured, distal 
oesophageal acid exposure. These results support the hypothesis that cardiac 
mucosa may be acquired and due to mechanisms other than traditional gastro-
oesophageal reflux. 
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Table 10.1 Median parietal cell density results 
 Location of Biopsies 
Group SCJ 1cm Distal to SCJ Gastric Body Gastric Antrum 
Total* 
5.4 
(0-16.3) 
26.5 
(6.7-34.7) 
31.2 
(19.9-42.7) 
2.5 
(0-21.3) 
<30 years old 
6.3 
(0-16.3) 
22.3 
(6.7-34.7) 
30.0 
(19.9-35.7) 
3.2 
(0-21.3) 
≥30 years old 
0.2 
(0-6.3) 
26.9 
(12.1-34.7) 
34.0 
(30.5-42.7) 
2.5 
(0-20.0) 
*Median (range in brackets) parietal cell densities are shown as % of total number of cells 
per biopsy section 
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Figure 10.1 Histology Slide showing parietal cells stained with monoclonal anti-
H+/K+ATPase antibody 
 
Figure 10.2 Fitted line plot of SCJ parietal cell density versus age 
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Figure 10.3. Bar chart of parietal cell densities at the SCJ and gastric body of Helicobacter 
Pylori negative subjects below and above 30 years of age 
 
Figure 10.4. Fitted line plot of distal oesophageal acid exposure versus SCJ parietal cell 
density 
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Chapter 11 
Discussion and Future Work 
7.1. Discussion 
This thesis describes a number of studies which provide further insight into 
the possible aetiological mechanisms which underpin the development of acid-
induced distal oesophageal squamous mucosal damage. 
In examining the role of salivary nitrite in the pathogenesis of GORD using 
healthy volunteers (Chapters 6, 7 and 8), we have produced the most robust study in 
this area to date. We were able to effectively control for variability in dietary nitrate 
consumption, as demonstrated by the negligible basal salivary nitrite concentrations. 
Furthermore, we produced an excellent range of salivary nitrite concentrations 
throughout these studies, over and above the normal physiological range. The total 
nitrite load was equivalent to that used in the previous study by Manning et al in 
which an increase in TLOSRs and acid exposure was seen following the infusion of 
a NO-generating infusion. However, in contrast to the study by Manning et al, by 
infusing nitrite solutions intra-orally without the addition of supra-physiological 
amounts of NO-promoting ascorbic acid, our study is more physiological in design. 
Despite this, these studies show no effect of salivary nitrite on gastro-oesophageal 
function, GOJ morphology or gastro-oesophageal reflux – either conventional or 
short-segment. This suggests that salivary nitrite does not alter gastro-oesophageal 
function, the integrity of the gastro-oesophageal barrier or gastro-oesophageal reflux. 
A criticism of these studies could be that only healthy volunteers were 
examined. This raises the possibility that an effect of salivary nitrite, and the luminal 
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chemicals it generates at the GOJ following ingestion, that is isolated to reflux 
patients may have been missed as this group has not been evaluated. Theoretically, 
the epithelial damage produced by erosive oesophagitis might facilitate NO reaching 
the intrinsic muscle layers of the oesophagus making reflux patients more sensitive 
to the presence of luminal NO than our healthy volunteers. However, given that in 
these studies the luminal nitrite concentrations following infusion of the highest 
concentration solution were 10-fold the upper limit of the normal range, it is unlikely 
an effect has been missed even in subjects with an intact epithelium. 
The heterogeneous nature of reflux patients – from those with abnormal 24 
hour acid exposure but non-erosive disease to patients with large hiatus hernia, 
long-segment Barrett’s oesophagus and severe (LA grade D) oesophagitis – makes 
them a difficult population to study. Moreover, as the majority of patients with 
confirmed reflux disease are likely to be receiving acid suppressing medical 
treatment with either a proton-pump inhibitor (PPI) or histamine-2 antagonist (H2A), 
attempts to study this population may be complicated by the phenomenon of 
rebound acid hypersecretion. This occurs after discontinuation of anti-secretory 
therapy and previous work by Gillen et al (172) and Fossmark et al (173) have 
shown this effect to be prolonged, lasting at least 8 weeks in Helicobacter Pylori 
negative individuals following PPI withdrawal. In symptomatic patients it is 
impractical to request discontinuation of acid suppression for this duration. As a 
result, being able to study ‘true’ reflux patients without pharmacological influence to 
either reduce or, through rebound hypersecretion, increase acid secretion is 
increasingly difficult. 
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 These studies are also the first studies examining the effect of salivary nitrite 
on GORD to utilise high-resolution pH and manometry techniques. While this 
provides high-frequency and detailed steady state analysis of gastro-oesophageal 
function, the volume of data produced and the complexity of data analysis is 
challenging and time-consuming. It has necessitated the development of our own in-
house custom-made analysis programmes and the development of a specific 
thermal drift correction to ensure the most accurate data analysis (151). However, 
being able to confirm, with a high level of significance, previously published 
physiological meal-induced changes at the GOJ confirm our study protocols and 
methods are both sensitive and robust. 
 A further question is whether the effect of salivary nitrite on gastro-
oesophageal function, morphology and reflux could be masked by the effect of the 
meal itself? It is well recognised that fatty meals, as result of increased CCK release 
secondary to duodenal fat, reduce LOS pressure, delay gastric emptying and may 
stimulate TLOSRs (22;54;55). Similarly, high volume meals may stimulate TLOSRs 
through gastric distension (23). We purposefully selected a low-fat meal to minimise 
the risk of this occurring. Importantly, the meal selected for these studies is likely to 
be both a lower volume and lower fat meal than the battered fish and chips meal 
used in the study by Manning et al (93) where an increase in TLOSRs and acid 
exposure is described following infusion of their NO-generating solution. Accordingly, 
it is unlikely that the meal used in our studies would mask any effect of salivary nitrite 
especially in view of the range of salivary nitrite concentrations produced. 
 The semi-recumbent position was used in all studies, however, this is not 
physiological following a meal as most patients are either mobile or sitting upright. 
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Therefore, the question remains whether these results are applicable to ambulant 
subjects or would be seen in subjects sitting upright following a meal. 
 The manometry studies in Chapters 6 and 8 also confirm, for the first time 
using high-resolution manometry, distal opening of the LOS after meals. This is a 
possible mechanism of distal oesophageal acidification independent of traditional 
‘trans-sphincteric’ reflux. Although in our detailed studies of GOJ morphology 
(Chapter 8) we did not see significant proximal migration of the pH step-up point 
across the SCJ this may be the result of examining a non-obese population in a 
semi-recumbent position.  
In our study examining the effect of age and obesity on SCJ position in 
healthy volunteers (Chapter 9) it could be argued that the results, showing a 
significant negative correlation between SCJ position relative to the proximal margin 
of the HPZ and age, BMI and waist circumference respectively, provide in vivo 
evidence to support the ‘acquired cardia’ hypothesis. Moreover, these results, which 
are more significant in the male sub-group, highlight a potential link to obesity and 
more specifically the visceral obesity which predominates in white males. This may 
be important in the pathogenesis of GOJ adenocarcinoma especially in the 
asymptomatic population. These results are underlined by the study in Chapter 10 
where a localised decrease in parietal cell density is seen at the SCJ. This appears 
to be independent of traditional trans-sphincteric reflux measured as distal 
oesophageal acid exposure. 
However, both these studies have obvious limitations with small number of 
subjects examined and limited age, BMI and waist circumference ranges. 
Importantly, both studies are cross-sectional and although they may highlight an 
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association they are unable to prove cause and effect. Despite this, the highly 
significant correlations deserve further investigation. 
 
7.2. Future Work 
Although our studies suggest that salivary nitrite does not promote gastro-
oesophageal reflux this does not mean that the luminal chemistry produced by 
swallowed nitrite does not still have a role to play in carcinogenesis at the GOJ. The 
nitrosating species N2O3 and NOSCN are able to react with secondary amines and 
amides in gastric juice to form N-nitroso compounds which induce cancer in animal 
models while nitric oxide is itself known to be mutagenic at high doses. To 
investigate whether a causal relationship exists between salivary nitrite produced 
from dietary nitrate and neoplasia at the GOJ will require large scale epidemiological 
studies. 
The GOJ and, in particular, the highly mobile SCJ remains a difficult area to 
study in great detail. In these studies, like many others, we used X-ray localisation 
with fluoroscopy to determine the location of the SCJ. While this can currently be 
considered the ‘gold standard’ its use in prolonged studies and appropriateness for 
detecting episodic changes in GOJ morphology (e.g. TLOSRs) is significantly limited 
by the radiation exposure involved. More work is needed to develop alternative 
techniques for investigating this dynamic and highly clinically important region. 
 Further work is also required to clarify the contribution of distal opening of the 
LOS to acidification, inflammation, metaplasia and neoplasia of the most distal 
oesophageal squamous mucosa. Future studies should be larger with greater range 
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in age, BMI and waist circumference. They should examine the effect of both obesity 
and posture. In particular, the supine posture which promotes cephalic displacement 
of the diaphragm and may precipitate distal opening. It would also be important to 
formally quantify visceral adiposity by utilising CT or MRI scanning and to investigate 
the effect of this visceral adiposity on the structures involved in maintaining the 
normal anti-reflux barrier such as the position of the crural diaphragm relative to the 
GOJ. Finally, further in vivo evidence is required to support the ‘acquired cardia’ 
hypothesis and subsequent studies may wish to examine the histology across the 
SCJ and gastric cardia in greater detail than simply quantifying parietal cell density. 
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